# Abbott Laboratories timeline entity: /record/abbott-laboratories.md id: ent_abbott-laboratories Abbott Laboratories' timeline holds 547 claims from 2006 to 2026: 1 people, 535 money & deals, 11 other. 10 are undated. The latest took effect on September 30, 2026. Kinds: People 1 (/timelines/abbott-laboratories.md?kind=people) · Money & deals 535 (/timelines/abbott-laboratories.md?kind=money) · Products 0 (/timelines/abbott-laboratories.md?kind=products) · Models 0 (/timelines/abbott-laboratories.md?kind=models) · Other 11 (/timelines/abbott-laboratories.md?kind=other) Format: date | kind | predicate | value | status | claim. ## 2006 - 2006-12-31 to 2007-12-31 | money | cash_and_equivalents | 521,192,000 United States dollar | superseded | [clm_EA473BD097AA](/claim/clm_EA473BD097AA.md) - 2006-12-31 to 2007-12-31 | money | total_equity | 14,054,186,000 United States dollar | superseded | [clm_43978D9CD2C9](/claim/clm_43978D9CD2C9.md) ## 2007 - 2007-12-31 to 2008-06-30 | money | cash_and_equivalents | 2,456,384,000 United States dollar | superseded | [clm_06133819F221](/claim/clm_06133819F221.md) - 2007-12-31 to 2008-12-31 | money | operating_income | 4,578,545,000 United States dollar | superseded | [clm_F857B97BF253](/claim/clm_F857B97BF253.md) - 2007-12-31 to 2008-12-31 | money | revenue | 25,914,238,000 United States dollar | superseded | [clm_1AE9E329ED59](/claim/clm_1AE9E329ED59.md) - 2007-12-31 to 2008-12-31 | money | total_assets | 39,713,924,000 United States dollar | superseded | [clm_08CB81E0BF16](/claim/clm_08CB81E0BF16.md) - 2007-12-31 to 2008-12-31 | money | total_equity | 17,778,540,000 United States dollar | superseded | [clm_EC2D6AAD0FF7](/claim/clm_EC2D6AAD0FF7.md) ## 2008 - 2008-06-30 to 2008-09-30 | money | cash_and_equivalents | 3,796,586,000 United States dollar | superseded | [clm_9FCEFBC20CAB](/claim/clm_9FCEFBC20CAB.md) - 2008-06-30 to 2008-09-30 | money | quarterly_operating_income | 1,406,585,000 United States dollar | superseded | [clm_611637E5B583](/claim/clm_611637E5B583.md) - 2008-06-30 to 2008-09-30 | money | quarterly_revenue | 7,314,021,000 United States dollar | superseded | [clm_53BF00022ED3](/claim/clm_53BF00022ED3.md) - 2008-09-30 to 2008-12-31 | money | cash_and_equivalents | 2,810,343,000 United States dollar | superseded | [clm_AD5025D43C51](/claim/clm_AD5025D43C51.md) - 2008-09-30 to 2009-03-31 | money | quarterly_operating_income | 1,396,517,000 United States dollar | superseded | [clm_EE3783948414](/claim/clm_EE3783948414.md) - 2008-09-30 to 2009-03-31 | money | quarterly_revenue | 7,497,660,000 United States dollar | superseded | [clm_79675DAFEFFB](/claim/clm_79675DAFEFFB.md) - 2008-12-31 to 2009-03-31 | money | cash_and_equivalents | 4,112,022,000 United States dollar | superseded | [clm_DE2BC508C752](/claim/clm_DE2BC508C752.md) - 2008-12-31 to 2009-12-31 | money | operating_income | 5,693,839,000 United States dollar | superseded | [clm_9A47D1F92763](/claim/clm_9A47D1F92763.md) - 2008-12-31 to 2009-12-31 | money | revenue | 29,527,552,000 United States dollar | superseded | [clm_F17A9DA7A446](/claim/clm_F17A9DA7A446.md) - 2008-12-31 to 2009-06-30 | money | total_assets | 42,419,204,000 United States dollar | superseded | [clm_90CA3B235E37](/claim/clm_90CA3B235E37.md) - 2008-12-31 to 2009-06-30 | money | total_equity | 17,479,551,000 United States dollar | superseded | [clm_34A4F9C5D46A](/claim/clm_34A4F9C5D46A.md) ## 2009 - 2009-03-31 to 2009-06-30 | money | cash_and_equivalents | 4,874,795,000 United States dollar | superseded | [clm_CD7C420909AE](/claim/clm_CD7C420909AE.md) - 2009-03-31 to 2009-06-30 | money | quarterly_operating_income | 1,060,759,000 United States dollar | superseded | [clm_BF0249D28592](/claim/clm_BF0249D28592.md) - 2009-03-31 to 2009-06-30 | money | quarterly_revenue | 6,718,368,000 United States dollar | superseded | [clm_6D1B34C8DAA9](/claim/clm_6D1B34C8DAA9.md) - 2009-06-30 to 2009-09-30 | money | cash_and_equivalents | 4,204,304,000 United States dollar | superseded | [clm_7367F0AB540E](/claim/clm_7367F0AB540E.md) - 2009-06-30 to 2009-09-30 | money | quarterly_operating_income | 1,671,420,000 United States dollar | superseded | [clm_998AAAD07809](/claim/clm_998AAAD07809.md) - 2009-06-30 to 2009-09-30 | money | quarterly_revenue | 7,494,876,000 United States dollar | superseded | [clm_3BEDCDE314E8](/claim/clm_3BEDCDE314E8.md) - 2009-06-30 to 2009-09-30 | money | shares_outstanding | 1,545,912,443 shares | superseded | [clm_5CA03662740C](/claim/clm_5CA03662740C.md) - 2009-06-30 to 2009-09-30 | money | total_assets | 47,630,017,000 United States dollar | superseded | [clm_D6BE0F2C8B81](/claim/clm_D6BE0F2C8B81.md) - 2009-06-30 to 2009-09-30 | money | total_equity | 19,879,112,000 United States dollar | superseded | [clm_31EB1925EF50](/claim/clm_31EB1925EF50.md) - 2009-09-30 to 2009-12-31 | money | cash_and_equivalents | 4,875,915,000 United States dollar | superseded | [clm_359398B95B4A](/claim/clm_359398B95B4A.md) - 2009-09-30 to 2010-03-31 | money | quarterly_operating_income | 1,639,753,000 United States dollar | superseded | [clm_939A0E0F91C1](/claim/clm_939A0E0F91C1.md) - 2009-09-30 to 2010-03-31 | money | quarterly_revenue | 7,761,336,000 United States dollar | superseded | [clm_F40C461D1F9A](/claim/clm_F40C461D1F9A.md) - 2009-09-30 to 2010-01-31 | money | shares_outstanding | 1,546,738,426 shares | superseded | [clm_2777291C1D6A](/claim/clm_2777291C1D6A.md) - 2009-09-30 to 2009-12-31 | money | total_assets | 49,846,820,000 United States dollar | superseded | [clm_369D8CA1A11D](/claim/clm_369D8CA1A11D.md) - 2009-09-30 to 2009-12-31 | money | total_equity | 21,335,055,000 United States dollar | superseded | [clm_BBD426555711](/claim/clm_BBD426555711.md) - 2009-12-31 to 2010-03-31 | money | cash_and_equivalents | 8,809,339,000 United States dollar | superseded | [clm_68D91286EA36](/claim/clm_68D91286EA36.md) - 2009-12-31 to 2010-12-31 | money | operating_income | 6,235,741,000 United States dollar | superseded | [clm_44311C0CCB22](/claim/clm_44311C0CCB22.md) - 2009-12-31 to 2010-12-31 | money | revenue | 30,764,707,000 United States dollar | superseded | [clm_BF21BA903CA4](/claim/clm_BF21BA903CA4.md) - 2009-12-31 to 2010-03-31 | money | total_assets | 52,416,623,000 United States dollar | superseded | [clm_D9EBDA9C23A0](/claim/clm_D9EBDA9C23A0.md) - 2009-12-31 to 2010-03-31 | money | total_equity | 22,855,627,000 United States dollar | superseded | [clm_B8C5187C21F8](/claim/clm_B8C5187C21F8.md) ## 2010 - 2010-01-31 to 2010-03-31 | money | shares_outstanding | 1,552,643,385 shares | superseded | [clm_55DE04E4C63E](/claim/clm_55DE04E4C63E.md) - 2010-03-31 to 2010-06-30 | money | cash_and_equivalents | 1,566,820,000 United States dollar | superseded | [clm_8831A07FE77A](/claim/clm_8831A07FE77A.md) - 2010-03-31 to 2010-06-30 | money | quarterly_operating_income | 1,470,483,000 United States dollar | superseded | [clm_A7FED0A7C490](/claim/clm_A7FED0A7C490.md) - 2010-03-31 to 2010-06-30 | money | quarterly_revenue | 7,698,354,000 United States dollar | superseded | [clm_882692ECC7C2](/claim/clm_882692ECC7C2.md) - 2010-03-31 to 2010-06-30 | money | shares_outstanding | 1,543,565,059 shares | superseded | [clm_4A1D932E0016](/claim/clm_4A1D932E0016.md) - 2010-03-31 to 2010-06-30 | money | total_assets | 53,358,622,000 United States dollar | superseded | [clm_E59D8BD6F57C](/claim/clm_E59D8BD6F57C.md) - 2010-03-31 to 2010-06-30 | money | total_equity | 20,860,099,000 United States dollar | superseded | [clm_85CABEE68CB1](/claim/clm_85CABEE68CB1.md) - 2010-06-30 to 2010-09-30 | money | cash_and_equivalents | 4,321,702,000 United States dollar | superseded | [clm_CBC630AE4E8D](/claim/clm_CBC630AE4E8D.md) - 2010-06-30 to 2010-09-30 | money | quarterly_operating_income | 1,605,966,000 United States dollar | superseded | [clm_0D38DCBAC1D9](/claim/clm_0D38DCBAC1D9.md) - 2010-06-30 to 2010-09-30 | money | quarterly_revenue | 8,826,014,000 United States dollar | superseded | [clm_BC7C9A4BD8E1](/claim/clm_BC7C9A4BD8E1.md) - 2010-06-30 to 2010-09-30 | money | shares_outstanding | 1,544,028,722 shares | superseded | [clm_9A07F66DD2FF](/claim/clm_9A07F66DD2FF.md) - 2010-06-30 to 2010-09-30 | money | total_assets | 53,381,402,000 United States dollar | superseded | [clm_CCF6757E8FC3](/claim/clm_CCF6757E8FC3.md) - 2010-06-30 to 2010-09-30 | money | total_equity | 19,911,709,000 United States dollar | superseded | [clm_90D583BDBB9B](/claim/clm_90D583BDBB9B.md) - 2010-09-30 to 2010-12-31 | money | cash_and_equivalents | 3,818,145,000 United States dollar | superseded | [clm_3550C577271B](/claim/clm_3550C577271B.md) - 2010-09-30 to 2011-03-31 | money | quarterly_operating_income | 1,181,185,000 United States dollar | superseded | [clm_5422E43B6140](/claim/clm_5422E43B6140.md) - 2010-09-30 to 2011-03-31 | money | quarterly_revenue | 8,674,505,000 United States dollar | superseded | [clm_A55F00358DA8](/claim/clm_A55F00358DA8.md) - 2010-09-30 to 2011-01-31 | money | shares_outstanding | 1,545,815,965 shares | superseded | [clm_E1CB9197DEA5](/claim/clm_E1CB9197DEA5.md) - 2010-09-30 to 2010-12-31 | money | total_assets | 57,373,620,000 United States dollar | superseded | [clm_0A2F6FD9A825](/claim/clm_0A2F6FD9A825.md) - 2010-09-30 to 2010-12-31 | money | total_equity | 21,403,932,000 United States dollar | superseded | [clm_F1A1F85FFC33](/claim/clm_F1A1F85FFC33.md) - 2010-12-31 to 2011-03-31 | money | cash_and_equivalents | 3,648,371,000 United States dollar | superseded | [clm_9C0B558E781A](/claim/clm_9C0B558E781A.md) - 2010-12-31 to 2011-12-31 | money | operating_income | 6,087,581,000 United States dollar | superseded | [clm_16CB3FB094C5](/claim/clm_16CB3FB094C5.md) - 2010-12-31 to 2011-12-31 | money | revenue | 35,166,721,000 United States dollar | superseded | [clm_FBAB25A659DE](/claim/clm_FBAB25A659DE.md) - 2010-12-31 to 2011-03-31 | money | total_assets | 59,462,266,000 United States dollar | superseded | [clm_273981693F13](/claim/clm_273981693F13.md) - 2010-12-31 to 2011-03-31 | money | total_equity | 22,388,135,000 United States dollar | superseded | [clm_D23ECD8FDCAC](/claim/clm_D23ECD8FDCAC.md) ## 2011 - 2011-01-31 to 2011-03-31 | money | shares_outstanding | 1,547,581,805 shares | superseded | [clm_0410A6F2C43D](/claim/clm_0410A6F2C43D.md) - 2011-03-31 to 2011-06-30 | money | cash_and_equivalents | 2,740,156,000 United States dollar | superseded | [clm_B1458938F400](/claim/clm_B1458938F400.md) - 2011-03-31 to 2011-06-30 | money | quarterly_operating_income | 1,301,149,000 United States dollar | superseded | [clm_D67FB10D44D3](/claim/clm_D67FB10D44D3.md) - 2011-03-31 to 2011-06-30 | money | quarterly_revenue | 9,040,850,000 United States dollar | superseded | [clm_E6DA945AC1D9](/claim/clm_E6DA945AC1D9.md) - 2011-03-31 to 2011-06-30 | money | shares_outstanding | 1,554,282,988 shares | superseded | [clm_0C2AEF8174B5](/claim/clm_0C2AEF8174B5.md) - 2011-03-31 to 2011-06-30 | money | total_assets | 61,651,363,000 United States dollar | superseded | [clm_4050A1B04C96](/claim/clm_4050A1B04C96.md) - 2011-03-31 to 2011-06-30 | money | total_equity | 24,629,650,000 United States dollar | superseded | [clm_5DCA28624EBB](/claim/clm_5DCA28624EBB.md) - 2011-06-30 to 2011-09-30 | money | cash_and_equivalents | 4,077,018,000 United States dollar | superseded | [clm_507982939D85](/claim/clm_507982939D85.md) - 2011-06-30 to 2011-09-30 | money | quarterly_operating_income | 1,773,453,000 United States dollar | superseded | [clm_19A69695BB00](/claim/clm_19A69695BB00.md) - 2011-06-30 to 2011-09-30 | money | quarterly_revenue | 9,616,291,000 United States dollar | superseded | [clm_2BC0D1181F4B](/claim/clm_2BC0D1181F4B.md) - 2011-06-30 to 2011-09-30 | money | shares_outstanding | 1,556,576,533 shares | superseded | [clm_8274522F4DD8](/claim/clm_8274522F4DD8.md) - 2011-06-30 to 2011-09-30 | money | total_assets | 62,004,241,000 United States dollar | superseded | [clm_6D8509B0B286](/claim/clm_6D8509B0B286.md) - 2011-06-30 to 2011-09-30 | money | total_equity | 26,378,853,000 United States dollar | superseded | [clm_6DF1F94B8785](/claim/clm_6DF1F94B8785.md) - 2011-08-22 | other | x_username | AbbottNews | unverified | [clm_4CCD509B66A0](/claim/clm_4CCD509B66A0.md) - 2011-09-30 to 2011-12-31 | money | cash_and_equivalents | 5,049,299,000 United States dollar | superseded | [clm_49FCEA1321DC](/claim/clm_49FCEA1321DC.md) - 2011-09-30 to 2012-03-31 | money | quarterly_operating_income | 594,878,000 United States dollar | superseded | [clm_83E5B8F4B133](/claim/clm_83E5B8F4B133.md) - 2011-09-30 to 2012-03-31 | money | quarterly_revenue | 9,816,665,000 United States dollar | superseded | [clm_60A7CF8613BF](/claim/clm_60A7CF8613BF.md) - 2011-09-30 to 2012-01-31 | money | shares_outstanding | 1,557,795,578 shares | superseded | [clm_E7CEC88C5131](/claim/clm_E7CEC88C5131.md) - 2011-09-30 to 2011-12-31 | money | total_assets | 59,628,176,000 United States dollar | superseded | [clm_E8CD9FA5F500](/claim/clm_E8CD9FA5F500.md) - 2011-09-30 to 2011-12-31 | money | total_equity | 24,603,800,000 United States dollar | superseded | [clm_B0304BE94341](/claim/clm_B0304BE94341.md) - 2011-12-31 to 2012-03-31 | money | cash_and_equivalents | 6,812,820,000 United States dollar | superseded | [clm_FC9A90EC2807](/claim/clm_FC9A90EC2807.md) - 2011-12-31 to 2012-12-31 | money | net_income | 4,728,000,000 United States dollar | superseded | [clm_E3BAB111231C](/claim/clm_E3BAB111231C.md) - 2011-12-31 to 2012-12-31 | money | operating_income | 5,751,948,000 United States dollar | superseded | [clm_E857AF3C6172](/claim/clm_E857AF3C6172.md) - 2011-12-31 to 2012-12-31 | money | revenue | 38,851,259,000 United States dollar | superseded | [clm_80F33B0D967B](/claim/clm_80F33B0D967B.md) - 2011-12-31 to 2012-03-31 | money | total_assets | 60,276,893,000 United States dollar | superseded | [clm_E061E4681AB9](/claim/clm_E061E4681AB9.md) - 2011-12-31 to 2012-03-31 | money | total_equity | 24,439,833,000 United States dollar | superseded | [clm_09169A44136C](/claim/clm_09169A44136C.md) ## 2012 - 2012-01-31 to 2012-03-31 | money | shares_outstanding | 1,572,356,859 shares | superseded | [clm_E1EBF63517AF](/claim/clm_E1EBF63517AF.md) - 2012-03-31 to 2012-06-30 | money | cash_and_equivalents | 4,345,910,000 United States dollar | superseded | [clm_E1E87B6DD7DE](/claim/clm_E1E87B6DD7DE.md) - 2012-03-31 to 2012-06-30 | money | quarterly_operating_income | 1,575,722,000 United States dollar | superseded | [clm_21EACF91396A](/claim/clm_21EACF91396A.md) - 2012-03-31 to 2018-03-31 | money | quarterly_research_and_development | 50,000,000 United States dollar | superseded | [clm_F26A204C1C56](/claim/clm_F26A204C1C56.md) - 2012-03-31 to 2012-06-30 | money | quarterly_revenue | 9,456,633,000 United States dollar | superseded | [clm_D9ABEC05FB6F](/claim/clm_D9ABEC05FB6F.md) - 2012-03-31 to 2012-06-30 | money | shares_outstanding | 1,573,391,467 shares | superseded | [clm_1DFA7D7F2069](/claim/clm_1DFA7D7F2069.md) - 2012-03-31 to 2012-06-30 | money | total_assets | 62,415,801,000 United States dollar | superseded | [clm_311FA36284F8](/claim/clm_311FA36284F8.md) - 2012-03-31 to 2012-06-30 | money | total_equity | 25,453,691,000 United States dollar | superseded | [clm_6B7C46E76D25](/claim/clm_6B7C46E76D25.md) - 2012-06-30 to 2012-09-30 | money | cash_and_equivalents | 7,052,776,000 United States dollar | superseded | [clm_9250460C542F](/claim/clm_9250460C542F.md) - 2012-06-30 to 2012-09-30 | money | quarterly_operating_income | 2,104,421,000 United States dollar | superseded | [clm_49FD4920B6B3](/claim/clm_49FD4920B6B3.md) - 2012-06-30 to 2012-09-30 | money | quarterly_revenue | 9,807,100,000 United States dollar | superseded | [clm_4F0F9A9FCDF2](/claim/clm_4F0F9A9FCDF2.md) - 2012-06-30 to 2012-09-30 | money | shares_outstanding | 1,569,333,729 shares | superseded | [clm_9CD0F79343E3](/claim/clm_9CD0F79343E3.md) - 2012-06-30 to 2012-09-30 | money | total_assets | 61,859,790,000 United States dollar | superseded | [clm_D512D0F32419](/claim/clm_D512D0F32419.md) - 2012-06-30 to 2012-09-30 | money | total_equity | 24,486,960,000 United States dollar | superseded | [clm_40993F6FAAEB](/claim/clm_40993F6FAAEB.md) - 2012-09-30 to 2012-12-31 | money | cash_and_equivalents | 7,996,948,000 United States dollar | superseded | [clm_485B77DCC4E1](/claim/clm_485B77DCC4E1.md) - 2012-09-30 to 2013-03-31 | money | quarterly_operating_income | 1,989,053,000 United States dollar | superseded | [clm_03034FC0B962](/claim/clm_03034FC0B962.md) - 2012-09-30 to 2013-03-31 | money | quarterly_revenue | 9,773,241,000 United States dollar | superseded | [clm_B817BB7C1C39](/claim/clm_B817BB7C1C39.md) - 2012-09-30 to 2013-01-31 | money | shares_outstanding | 1,580,667,737 shares | superseded | [clm_A5733B5B97F8](/claim/clm_A5733B5B97F8.md) - 2012-09-30 to 2012-12-31 | money | total_assets | 63,257,738,000 United States dollar | superseded | [clm_0F6ED49CB4F4](/claim/clm_0F6ED49CB4F4.md) - 2012-09-30 to 2012-12-31 | money | total_equity | 27,014,175,000 United States dollar | superseded | [clm_CAE9CB28DB1F](/claim/clm_CAE9CB28DB1F.md) - 2012-12-31 to 2013-03-31 | money | cash_and_equivalents | 10,802,163,000 United States dollar | superseded | [clm_FEB167E490AD](/claim/clm_FEB167E490AD.md) - 2012-12-31 to 2013-12-31 | money | net_income | 5,963,000,000 United States dollar | superseded | [clm_E0C8ECF41AD1](/claim/clm_E0C8ECF41AD1.md) - 2012-12-31 to 2013-12-31 | money | operating_income | 8,084,515,000 United States dollar | superseded | [clm_DB14BAE02A47](/claim/clm_DB14BAE02A47.md) - 2012-12-31 to 2013-12-31 | money | revenue | 39,873,910,000 United States dollar | superseded | [clm_B4C1932FF6FA](/claim/clm_B4C1932FF6FA.md) - 2012-12-31 to 2013-03-31 | money | total_assets | 67,234,944,000 United States dollar | superseded | [clm_B8A0C7E5A98B](/claim/clm_B8A0C7E5A98B.md) - 2012-12-31 to 2013-03-31 | money | total_equity | 26,720,961,000 United States dollar | superseded | [clm_24230E6F3612](/claim/clm_24230E6F3612.md) ## 2013 - 2013-01-31 to 2013-03-31 | money | shares_outstanding | 1,570,677,029 shares | superseded | [clm_EC2D60D2CF76](/claim/clm_EC2D60D2CF76.md) - 2013-03-31 to 2013-06-30 | money | cash_and_equivalents | 4,373,120,000 United States dollar | superseded | [clm_C0BA9C433C47](/claim/clm_C0BA9C433C47.md) - 2013-03-31 to 2013-06-30 | money | quarterly_net_income | 544,000,000 United States dollar | superseded | [clm_99925964117F](/claim/clm_99925964117F.md) - 2013-03-31 to 2013-06-30 | money | quarterly_operating_income | 614,788,000 United States dollar | superseded | [clm_C62521896403](/claim/clm_C62521896403.md) - 2013-03-31 to 2013-06-30 | money | quarterly_revenue | 5,377,895,000 United States dollar | superseded | [clm_83226985F7C5](/claim/clm_83226985F7C5.md) - 2013-03-31 to 2013-06-30 | money | shares_outstanding | 1,558,864,658 shares | superseded | [clm_DB844C28FB13](/claim/clm_DB844C28FB13.md) - 2013-03-31 to 2013-06-30 | money | total_assets | 42,686,613,000 United States dollar | superseded | [clm_765D69CF45D0](/claim/clm_765D69CF45D0.md) - 2013-03-31 to 2013-06-30 | money | total_equity | 22,588,186,000 United States dollar | superseded | [clm_CEDF1D0510CD](/claim/clm_CEDF1D0510CD.md) - 2013-06-30 to 2013-09-30 | money | cash_and_equivalents | 5,572,254,000 United States dollar | superseded | [clm_3B7BA4C79E00](/claim/clm_3B7BA4C79E00.md) - 2013-06-30 to 2013-09-30 | money | quarterly_net_income | 476,000,000 United States dollar | superseded | [clm_56D74673B58B](/claim/clm_56D74673B58B.md) - 2013-06-30 to 2013-09-30 | money | quarterly_operating_income | 627,476,000 United States dollar | superseded | [clm_A62E02723D32](/claim/clm_A62E02723D32.md) - 2013-06-30 to 2013-09-30 | money | quarterly_revenue | 5,446,025,000 United States dollar | superseded | [clm_A00248C0A983](/claim/clm_A00248C0A983.md) - 2013-06-30 to 2013-09-30 | money | shares_outstanding | 1,554,125,355 shares | superseded | [clm_31493028904E](/claim/clm_31493028904E.md) - 2013-06-30 to 2013-09-30 | money | total_assets | 42,903,346,000 United States dollar | superseded | [clm_01D207199632](/claim/clm_01D207199632.md) - 2013-06-30 to 2013-09-30 | money | total_equity | 22,336,064,000 United States dollar | superseded | [clm_FA0A4E638F4A](/claim/clm_FA0A4E638F4A.md) - 2013-09-30 to 2013-12-31 | money | cash_and_equivalents | 2,882,454,000 United States dollar | superseded | [clm_F56B3CD1FDAB](/claim/clm_F56B3CD1FDAB.md) - 2013-09-30 to 2014-03-31 | money | quarterly_net_income | 966,000,000 United States dollar | superseded | [clm_2BB6EFB82CB5](/claim/clm_2BB6EFB82CB5.md) - 2013-09-30 to 2014-03-31 | money | quarterly_operating_income | 630,339,000 United States dollar | superseded | [clm_102398756A32](/claim/clm_102398756A32.md) - 2013-09-30 to 2014-03-31 | money | quarterly_revenue | 5,369,138,000 United States dollar | superseded | [clm_05BD8CC8CEE0](/claim/clm_05BD8CC8CEE0.md) - 2013-09-30 to 2014-01-31 | money | shares_outstanding | 1,546,185,646 shares | superseded | [clm_03EB3A67DDC7](/claim/clm_03EB3A67DDC7.md) - 2013-09-30 to 2013-12-31 | money | total_assets | 44,132,477,000 United States dollar | superseded | [clm_498E70E89BD2](/claim/clm_498E70E89BD2.md) - 2013-09-30 to 2013-12-31 | money | total_equity | 23,696,237,000 United States dollar | superseded | [clm_CFE8748CEC34](/claim/clm_CFE8748CEC34.md) - 2013-12-31 to 2014-03-31 | money | cash_and_equivalents | 3,475,000,000 United States dollar | superseded | [clm_11779D774E56](/claim/clm_11779D774E56.md) - 2013-12-31 to 2014-12-31 | money | net_income | 2,576,000,000 United States dollar | superseded | [clm_C538B005C944](/claim/clm_C538B005C944.md) - 2013-12-31 to 2014-12-31 | money | operating_income | 2,629,000,000 United States dollar | superseded | [clm_476B36EDFB32](/claim/clm_476B36EDFB32.md) - 2013-12-31 to 2014-12-31 | money | revenue | 21,848,000,000 United States dollar | superseded | [clm_9516B11C6785](/claim/clm_9516B11C6785.md) - 2013-12-31 to 2014-03-31 | money | total_assets | 42,953,000,000 United States dollar | superseded | [clm_BE81EC5EFEDD](/claim/clm_BE81EC5EFEDD.md) - 2013-12-31 to 2014-03-31 | money | total_equity | 25,171,000,000 United States dollar | superseded | [clm_25A96CED8FE3](/claim/clm_25A96CED8FE3.md) ## 2014 - 2014-01-31 to 2014-03-31 | money | shares_outstanding | 1,543,070,300 shares | superseded | [clm_F3B60AD32165](/claim/clm_F3B60AD32165.md) - 2014-03-31 to 2014-06-30 | money | cash_and_equivalents | 2,060,000,000 United States dollar | superseded | [clm_DBA8DBEBFC34](/claim/clm_DBA8DBEBFC34.md) - 2014-03-31 to 2014-06-30 | money | quarterly_net_income | 375,000,000 United States dollar | superseded | [clm_604CF864E41B](/claim/clm_604CF864E41B.md) - 2014-03-31 to 2014-06-30 | money | quarterly_operating_income | 451,000,000 United States dollar | superseded | [clm_1937F4CF953B](/claim/clm_1937F4CF953B.md) - 2014-03-31 to 2014-06-30 | money | quarterly_revenue | 5,244,000,000 United States dollar | superseded | [clm_B233A6055639](/claim/clm_B233A6055639.md) - 2014-03-31 to 2014-06-30 | money | shares_outstanding | 1,501,938,538 shares | superseded | [clm_398EA7EAB5B8](/claim/clm_398EA7EAB5B8.md) - 2014-03-31 to 2014-06-30 | money | total_assets | 41,662,000,000 United States dollar | superseded | [clm_5B183F58E77F](/claim/clm_5B183F58E77F.md) - 2014-03-31 to 2014-06-30 | money | total_equity | 23,390,000,000 United States dollar | superseded | [clm_C84177F7FADC](/claim/clm_C84177F7FADC.md) - 2014-06-30 to 2014-09-30 | money | cash_and_equivalents | 3,570,000,000 United States dollar | superseded | [clm_AA75EDDF3D74](/claim/clm_AA75EDDF3D74.md) - 2014-06-30 to 2014-09-30 | money | quarterly_net_income | 466,000,000 United States dollar | superseded | [clm_B5440F9585CE](/claim/clm_B5440F9585CE.md) - 2014-06-30 to 2014-09-30 | money | quarterly_operating_income | 761,000,000 United States dollar | superseded | [clm_D93B193C9846](/claim/clm_D93B193C9846.md) - 2014-06-30 to 2014-09-30 | money | quarterly_revenue | 5,551,000,000 United States dollar | superseded | [clm_FD8317313DF1](/claim/clm_FD8317313DF1.md) - 2014-06-30 to 2014-09-30 | money | shares_outstanding | 1,503,699,033 shares | superseded | [clm_CDA367FBFDF8](/claim/clm_CDA367FBFDF8.md) - 2014-06-30 to 2014-09-30 | money | total_assets | 41,475,000,000 United States dollar | superseded | [clm_285888A38ED0](/claim/clm_285888A38ED0.md) - 2014-06-30 to 2014-09-30 | money | total_equity | 23,602,000,000 United States dollar | superseded | [clm_820EF0E3F09E](/claim/clm_820EF0E3F09E.md) - 2014-09-30 to 2014-12-31 | money | cash_and_equivalents | 3,613,000,000 United States dollar | superseded | [clm_D03CCE99B6F0](/claim/clm_D03CCE99B6F0.md) - 2014-09-30 to 2015-03-31 | money | quarterly_net_income | 538,000,000 United States dollar | superseded | [clm_D2D95C54C305](/claim/clm_D2D95C54C305.md) - 2014-09-30 to 2015-03-31 | money | quarterly_operating_income | 731,000,000 United States dollar | superseded | [clm_1340152CB9B1](/claim/clm_1340152CB9B1.md) - 2014-09-30 to 2015-03-31 | money | quarterly_revenue | 5,104,000,000 United States dollar | superseded | [clm_82A6A707FD7C](/claim/clm_82A6A707FD7C.md) - 2014-09-30 to 2015-01-31 | money | shares_outstanding | 1,505,790,586 shares | superseded | [clm_046691A1A0C0](/claim/clm_046691A1A0C0.md) - 2014-09-30 to 2014-12-31 | money | total_assets | 42,514,000,000 United States dollar | superseded | [clm_CF1CC29BF075](/claim/clm_CF1CC29BF075.md) - 2014-09-30 to 2014-12-31 | money | total_equity | 22,888,000,000 United States dollar | superseded | [clm_FE809BBE39B1](/claim/clm_FE809BBE39B1.md) - 2014-12-31 to 2015-03-31 | money | cash_and_equivalents | 4,063,000,000 United States dollar | superseded | [clm_29AA3D4C2CD2](/claim/clm_29AA3D4C2CD2.md) - 2014-12-31 to 2015-12-31 | money | net_income | 2,284,000,000 United States dollar | superseded | [clm_B11F523F3F14](/claim/clm_B11F523F3F14.md) - 2014-12-31 to 2015-12-31 | money | operating_income | 2,599,000,000 United States dollar | superseded | [clm_4095A5CF68FD](/claim/clm_4095A5CF68FD.md) - 2014-12-31 to 2015-12-31 | money | revenue | 20,247,000,000 United States dollar | superseded | [clm_0D3539091ADB](/claim/clm_0D3539091ADB.md) - 2014-12-31 to 2015-03-31 | money | total_assets | 41,275,000,000 United States dollar | superseded | [clm_2B6AC140F47C](/claim/clm_2B6AC140F47C.md) - 2014-12-31 to 2015-03-31 | money | total_equity | 21,526,000,000 United States dollar | superseded | [clm_D31BB3649B18](/claim/clm_D31BB3649B18.md) ## 2015 - 2015-01-31 to 2015-03-31 | money | shares_outstanding | 1,508,977,828 shares | superseded | [clm_01EFFCB41E1C](/claim/clm_01EFFCB41E1C.md) - 2015-03-31 to 2015-06-30 | money | cash_and_equivalents | 3,226,000,000 United States dollar | superseded | [clm_FF3EC9A8A46B](/claim/clm_FF3EC9A8A46B.md) - 2015-03-31 to 2015-06-30 | money | quarterly_net_income | 2,292,000,000 United States dollar | superseded | [clm_1C02430C4950](/claim/clm_1C02430C4950.md) - 2015-03-31 to 2015-06-30 | money | quarterly_operating_income | 610,000,000 United States dollar | superseded | [clm_93E168E8343C](/claim/clm_93E168E8343C.md) - 2015-03-31 to 2015-06-30 | money | quarterly_revenue | 4,897,000,000 United States dollar | superseded | [clm_217D209218A4](/claim/clm_217D209218A4.md) - 2015-03-31 to 2015-06-30 | money | shares_outstanding | 1,488,757,318 shares | superseded | [clm_B73D3A7A5FA7](/claim/clm_B73D3A7A5FA7.md) - 2015-03-31 to 2015-06-30 | money | total_assets | 43,095,000,000 United States dollar | superseded | [clm_32CF94AF39DB](/claim/clm_32CF94AF39DB.md) - 2015-03-31 to 2015-06-30 | money | total_equity | 21,874,000,000 United States dollar | superseded | [clm_B7BFE3FD70B5](/claim/clm_B7BFE3FD70B5.md) - 2015-06-30 to 2015-09-30 | money | cash_and_equivalents | 4,048,000,000 United States dollar | superseded | [clm_E79667D75AE6](/claim/clm_E79667D75AE6.md) - 2015-06-30 to 2015-09-30 | money | quarterly_net_income | 784,000,000 United States dollar | superseded | [clm_C09A927BCCDA](/claim/clm_C09A927BCCDA.md) - 2015-06-30 to 2015-09-30 | money | quarterly_operating_income | 729,000,000 United States dollar | superseded | [clm_E789F7FC62E7](/claim/clm_E789F7FC62E7.md) - 2015-06-30 to 2015-09-30 | money | quarterly_revenue | 5,170,000,000 United States dollar | superseded | [clm_1E113FF89F7B](/claim/clm_1E113FF89F7B.md) - 2015-06-30 to 2015-09-30 | money | shares_outstanding | 1,490,441,465 shares | superseded | [clm_771836F657A2](/claim/clm_771836F657A2.md) - 2015-06-30 to 2015-09-30 | money | total_assets | 44,125,000,000 United States dollar | superseded | [clm_BFEBD87BE412](/claim/clm_BFEBD87BE412.md) - 2015-06-30 to 2015-09-30 | money | total_equity | 23,008,000,000 United States dollar | superseded | [clm_D8D7C2D39205](/claim/clm_D8D7C2D39205.md) - 2015-09-30 to 2015-12-31 | money | cash_and_equivalents | 3,132,000,000 United States dollar | superseded | [clm_278DC080FBE9](/claim/clm_278DC080FBE9.md) - 2015-09-30 to 2016-03-31 | money | quarterly_net_income | 580,000,000 United States dollar | superseded | [clm_94B13D450A74](/claim/clm_94B13D450A74.md) - 2015-09-30 to 2016-03-31 | money | quarterly_operating_income | 713,000,000 United States dollar | superseded | [clm_0E1A644D6289](/claim/clm_0E1A644D6289.md) - 2015-09-30 to 2016-03-31 | money | quarterly_revenue | 5,150,000,000 United States dollar | superseded | [clm_4DDA3D71417E](/claim/clm_4DDA3D71417E.md) - 2015-09-30 to 2016-01-31 | money | shares_outstanding | 1,491,719,891 shares | superseded | [clm_96EE5B28A5A8](/claim/clm_96EE5B28A5A8.md) - 2015-09-30 to 2015-12-31 | money | total_assets | 41,725,000,000 United States dollar | superseded | [clm_5EAB483532A7](/claim/clm_5EAB483532A7.md) - 2015-09-30 to 2015-12-31 | money | total_equity | 21,111,000,000 United States dollar | superseded | [clm_32290A5FC0E4](/claim/clm_32290A5FC0E4.md) - 2015-12-31 to 2016-03-31 | money | cash_and_equivalents | 5,001,000,000 United States dollar | superseded | [clm_E25A94C67D09](/claim/clm_E25A94C67D09.md) - 2015-12-31 to 2016-12-31 | money | net_income | 4,423,000,000 United States dollar | superseded | [clm_E00F0EE99100](/claim/clm_E00F0EE99100.md) - 2015-12-31 to 2016-12-31 | money | operating_income | 2,867,000,000 United States dollar | superseded | [clm_D45686CBE9CE](/claim/clm_D45686CBE9CE.md) - 2015-12-31 to 2016-12-31 | money | revenue | 20,405,000,000 United States dollar | superseded | [clm_16E555E53E25](/claim/clm_16E555E53E25.md) - 2015-12-31 to 2016-03-31 | money | total_assets | 41,247,000,000 United States dollar | superseded | [clm_4DAF27B7700C](/claim/clm_4DAF27B7700C.md) - 2015-12-31 to 2016-03-31 | money | total_equity | 21,211,000,000 United States dollar | superseded | [clm_2369723DE4DA](/claim/clm_2369723DE4DA.md) ## 2016 - 2016-01-31 to 2016-03-31 | money | shares_outstanding | 1,473,241,861 shares | superseded | [clm_1B44F2DE8736](/claim/clm_1B44F2DE8736.md) - 2016-03-31 to 2016-06-30 | money | cash_and_equivalents | 3,334,000,000 United States dollar | superseded | [clm_1FC299F54EDD](/claim/clm_1FC299F54EDD.md) - 2016-03-31 to 2016-06-30 | money | quarterly_net_income | 316,000,000 United States dollar | superseded | [clm_0603855B1B45](/claim/clm_0603855B1B45.md) - 2016-03-31 to 2016-06-30 | money | quarterly_operating_income | 524,000,000 United States dollar | superseded | [clm_386CF61547F5](/claim/clm_386CF61547F5.md) - 2016-03-31 to 2016-06-30 | money | quarterly_revenue | 4,885,000,000 United States dollar | superseded | [clm_33CB344232AF](/claim/clm_33CB344232AF.md) - 2016-03-31 to 2016-06-30 | money | shares_outstanding | 1,469,152,033 shares | superseded | [clm_E22E26C7A5C9](/claim/clm_E22E26C7A5C9.md) - 2016-03-31 to 2016-06-30 | money | total_assets | 39,637,000,000 United States dollar | superseded | [clm_A72DE3456A35](/claim/clm_A72DE3456A35.md) - 2016-03-31 to 2016-06-30 | money | total_equity | 20,722,000,000 United States dollar | superseded | [clm_9E0E24B3E644](/claim/clm_9E0E24B3E644.md) - 2016-06-30 to 2016-09-30 | money | cash_and_equivalents | 2,578,000,000 United States dollar | superseded | [clm_FA8D28D995F1](/claim/clm_FA8D28D995F1.md) - 2016-06-30 to 2016-09-30 | money | quarterly_net_income | 615,000,000 United States dollar | superseded | [clm_D6BBD632FF41](/claim/clm_D6BBD632FF41.md) - 2016-06-30 to 2016-09-30 | money | quarterly_operating_income | 816,000,000 United States dollar | superseded | [clm_3ED6D1E2F97A](/claim/clm_3ED6D1E2F97A.md) - 2016-06-30 to 2016-09-30 | money | quarterly_revenue | 5,333,000,000 United States dollar | superseded | [clm_1B83117F5484](/claim/clm_1B83117F5484.md) - 2016-06-30 to 2016-09-30 | money | shares_outstanding | 1,469,995,415 shares | superseded | [clm_9FA1445E4402](/claim/clm_9FA1445E4402.md) - 2016-06-30 to 2016-09-30 | money | total_assets | 39,831,000,000 United States dollar | superseded | [clm_2A02207F2DFC](/claim/clm_2A02207F2DFC.md) - 2016-06-30 to 2016-09-30 | money | total_equity | 20,675,000,000 United States dollar | superseded | [clm_08EC8818E782](/claim/clm_08EC8818E782.md) - 2016-09-30 to 2016-12-31 | money | cash_and_equivalents | 2,500,000,000 United States dollar | superseded | [clm_6E48EACB3253](/claim/clm_6E48EACB3253.md) - 2016-09-30 to 2017-03-31 | money | quarterly_net_income | -329,000,000 United States dollar | superseded | [clm_5F39464983EE](/claim/clm_5F39464983EE.md) - 2016-09-30 to 2017-03-31 | money | quarterly_operating_income | 897,000,000 United States dollar | superseded | [clm_193539EFFD26](/claim/clm_193539EFFD26.md) - 2016-09-30 to 2017-03-31 | money | quarterly_revenue | 5,302,000,000 United States dollar | superseded | [clm_8064646C7C6E](/claim/clm_8064646C7C6E.md) - 2016-09-30 to 2017-01-31 | money | shares_outstanding | 1,472,309,523 shares | superseded | [clm_20D5B4C10A23](/claim/clm_20D5B4C10A23.md) - 2016-09-30 to 2016-12-31 | money | total_assets | 39,497,000,000 United States dollar | superseded | [clm_4DB8B69673CB](/claim/clm_4DB8B69673CB.md) - 2016-09-30 to 2016-12-31 | money | total_equity | 20,776,000,000 United States dollar | superseded | [clm_F5A188432375](/claim/clm_F5A188432375.md) - 2016-12-31 to 2017-03-31 | money | cash_and_equivalents | 18,620,000,000 United States dollar | superseded | [clm_30F5C427EA78](/claim/clm_30F5C427EA78.md) - 2016-12-31 to 2017-12-31 | money | net_income | 1,400,000,000 United States dollar | superseded | [clm_87CC51296794](/claim/clm_87CC51296794.md) - 2016-12-31 to 2017-12-31 | money | operating_income | 3,185,000,000 United States dollar | superseded | [clm_476A660B6C4B](/claim/clm_476A660B6C4B.md) - 2016-12-31 to 2017-12-31 | money | revenue | 20,853,000,000 United States dollar | superseded | [clm_305771785CD8](/claim/clm_305771785CD8.md) - 2016-12-31 to 2017-03-31 | money | total_assets | 52,666,000,000 United States dollar | superseded | [clm_152F5F758C41](/claim/clm_152F5F758C41.md) - 2016-12-31 to 2017-03-31 | money | total_equity | 20,538,000,000 United States dollar | superseded | [clm_8210275EABD7](/claim/clm_8210275EABD7.md) ## 2017 - 2017-01-31 to 2017-03-31 | money | shares_outstanding | 1,727,997,596 shares | superseded | [clm_D91F2017CC04](/claim/clm_D91F2017CC04.md) - 2017-03-31 to 2017-06-30 | money | cash_and_equivalents | 8,706,000,000 United States dollar | superseded | [clm_437931E6A03A](/claim/clm_437931E6A03A.md) - 2017-03-31 to 2017-06-30 | money | quarterly_net_income | 419,000,000 United States dollar | superseded | [clm_DD829B82B38C](/claim/clm_DD829B82B38C.md) - 2017-03-31 to 2017-06-30 | money | quarterly_operating_income | -202,000,000 United States dollar | superseded | [clm_47108AC0E4BE](/claim/clm_47108AC0E4BE.md) - 2017-03-31 to 2017-06-30 | money | quarterly_revenue | 6,335,000,000 United States dollar | superseded | [clm_15BAEA02B893](/claim/clm_15BAEA02B893.md) - 2017-03-31 to 2017-06-30 | money | shares_outstanding | 1,735,272,054 shares | superseded | [clm_301BDC9105FC](/claim/clm_301BDC9105FC.md) - 2017-03-31 to 2017-06-30 | money | total_assets | 70,887,000,000 United States dollar | superseded | [clm_FFC8F38C32CB](/claim/clm_FFC8F38C32CB.md) - 2017-03-31 to 2017-06-30 | money | total_equity | 31,362,000,000 United States dollar | superseded | [clm_B7DCB616777F](/claim/clm_B7DCB616777F.md) - 2017-06-30 to 2017-09-30 | money | cash_and_equivalents | 9,675,000,000 United States dollar | superseded | [clm_83F1FF1326CA](/claim/clm_83F1FF1326CA.md) - 2017-06-30 to 2017-09-30 | money | quarterly_net_income | 283,000,000 United States dollar | superseded | [clm_77D0019EBF2D](/claim/clm_77D0019EBF2D.md) - 2017-06-30 to 2017-09-30 | money | quarterly_operating_income | 427,000,000 United States dollar | superseded | [clm_2BF64D8B9D86](/claim/clm_2BF64D8B9D86.md) - 2017-06-30 to 2017-09-30 | money | quarterly_revenue | 6,637,000,000 United States dollar | superseded | [clm_29C8A48CFFA6](/claim/clm_29C8A48CFFA6.md) - 2017-06-30 to 2017-09-30 | money | shares_outstanding | 1,737,443,264 shares | superseded | [clm_0F510C806C66](/claim/clm_0F510C806C66.md) - 2017-06-30 to 2017-09-30 | money | total_assets | 71,151,000,000 United States dollar | superseded | [clm_CDC7CB62542B](/claim/clm_CDC7CB62542B.md) - 2017-06-30 to 2017-09-30 | money | total_equity | 31,602,000,000 United States dollar | superseded | [clm_E37A9F632E3D](/claim/clm_E37A9F632E3D.md) - 2017-09-30 to 2017-12-31 | money | cash_and_equivalents | 11,012,000,000 United States dollar | superseded | [clm_4689BDC0942B](/claim/clm_4689BDC0942B.md) - 2017-09-30 to 2018-03-31 | money | quarterly_net_income | 603,000,000 United States dollar | superseded | [clm_4061F715D3A7](/claim/clm_4061F715D3A7.md) - 2017-09-30 to 2018-03-31 | money | quarterly_operating_income | 810,000,000 United States dollar | superseded | [clm_77913BAAC587](/claim/clm_77913BAAC587.md) - 2017-09-30 to 2018-03-31 | money | quarterly_revenue | 6,829,000,000 United States dollar | superseded | [clm_402A58FFA584](/claim/clm_402A58FFA584.md) - 2017-09-30 to 2018-01-31 | money | shares_outstanding | 1,740,600,687 shares | superseded | [clm_00A19041C7EC](/claim/clm_00A19041C7EC.md) - 2017-09-30 to 2017-12-31 | money | total_assets | 72,248,000,000 United States dollar | superseded | [clm_129A9E1E6676](/claim/clm_129A9E1E6676.md) - 2017-09-30 to 2017-12-31 | money | total_equity | 32,032,000,000 United States dollar | superseded | [clm_E93715A27F70](/claim/clm_E93715A27F70.md) - 2017-12-31 to 2018-03-31 | money | cash_and_equivalents | 9,407,000,000 United States dollar | superseded | [clm_3F95EE2FABBF](/claim/clm_3F95EE2FABBF.md) - 2017-12-31 to 2018-12-31 | money | net_income | 477,000,000 United States dollar | superseded | [clm_0E0A2ADD6C11](/claim/clm_0E0A2ADD6C11.md) - 2017-12-31 to 2018-12-31 | money | operating_income | 1,726,000,000 United States dollar | superseded | [clm_4420320133D9](/claim/clm_4420320133D9.md) - 2017-12-31 to 2018-12-31 | money | research_and_development | 2,260,000,000 United States dollar | superseded | [clm_B40728D6F627](/claim/clm_B40728D6F627.md) - 2017-12-31 to 2018-12-31 | money | revenue | 27,390,000,000 United States dollar | superseded | [clm_CBCFC23B00BC](/claim/clm_CBCFC23B00BC.md) - 2017-12-31 to 2018-03-31 | money | total_assets | 76,250,000,000 United States dollar | superseded | [clm_60A75BEF73AA](/claim/clm_60A75BEF73AA.md) - 2017-12-31 to 2018-03-31 | money | total_equity | 30,897,000,000 United States dollar | superseded | [clm_9D7A48D859AE](/claim/clm_9D7A48D859AE.md) ## 2018 - 2018-01-31 to 2018-03-31 | money | shares_outstanding | 1,746,333,892 shares | superseded | [clm_749951A1C0C9](/claim/clm_749951A1C0C9.md) - 2018-03-31 to 2018-06-30 | money | cash_and_equivalents | 3,857,000,000 United States dollar | superseded | [clm_59EC592653CE](/claim/clm_59EC592653CE.md) - 2018-03-31 to 2018-06-30 | money | quarterly_net_income | 418,000,000 United States dollar | superseded | [clm_32DA1D18D30F](/claim/clm_32DA1D18D30F.md) - 2018-03-31 to 2018-06-30 | money | quarterly_operating_income | 608,000,000 United States dollar | superseded | [clm_455364238A9E](/claim/clm_455364238A9E.md) - 2018-03-31 to 2018-06-30 | money | quarterly_research_and_development | 589,000,000 United States dollar | superseded | [clm_D0387CB879C0](/claim/clm_D0387CB879C0.md) - 2018-03-31 to 2018-06-30 | money | quarterly_revenue | 7,390,000,000 United States dollar | superseded | [clm_C3C0F612B29F](/claim/clm_C3C0F612B29F.md) - 2018-03-31 to 2018-06-30 | money | shares_outstanding | 1,753,187,766 shares | superseded | [clm_4A012C69AC0E](/claim/clm_4A012C69AC0E.md) - 2018-03-31 to 2018-06-30 | money | total_assets | 70,908,000,000 United States dollar | superseded | [clm_A40F2BAB5CB1](/claim/clm_A40F2BAB5CB1.md) - 2018-03-31 to 2018-06-30 | money | total_equity | 31,399,000,000 United States dollar | superseded | [clm_D7620A7ABE34](/claim/clm_D7620A7ABE34.md) - 2018-06-30 to 2018-09-30 | money | cash_and_equivalents | 3,065,000,000 United States dollar | superseded | [clm_E32F9485C0C9](/claim/clm_E32F9485C0C9.md) - 2018-06-30 to 2018-09-30 | money | quarterly_net_income | 733,000,000 United States dollar | superseded | [clm_EA6CC4097E8D](/claim/clm_EA6CC4097E8D.md) - 2018-06-30 to 2018-09-30 | money | quarterly_operating_income | 882,000,000 United States dollar | superseded | [clm_3F5036ACEF86](/claim/clm_3F5036ACEF86.md) - 2018-06-30 to 2018-09-30 | money | quarterly_research_and_development | 575,000,000 United States dollar | superseded | [clm_6B0B3077A414](/claim/clm_6B0B3077A414.md) - 2018-06-30 to 2018-09-30 | money | quarterly_revenue | 7,767,000,000 United States dollar | superseded | [clm_79374FAAB118](/claim/clm_79374FAAB118.md) - 2018-06-30 to 2018-09-30 | money | shares_outstanding | 1,754,319,284 shares | superseded | [clm_9F7DBFC910F0](/claim/clm_9F7DBFC910F0.md) - 2018-06-30 to 2018-09-30 | money | total_assets | 68,415,000,000 United States dollar | superseded | [clm_4B97A512CC39](/claim/clm_4B97A512CC39.md) - 2018-06-30 to 2018-09-30 | money | total_equity | 30,577,000,000 United States dollar | superseded | [clm_9C4568F5F599](/claim/clm_9C4568F5F599.md) - 2018-09-30 to 2018-12-31 | money | cash_and_equivalents | 7,369,000,000 United States dollar | superseded | [clm_6AD344300D4A](/claim/clm_6AD344300D4A.md) - 2018-09-30 to 2019-03-31 | money | quarterly_net_income | 563,000,000 United States dollar | superseded | [clm_EA18E0C4D59D](/claim/clm_EA18E0C4D59D.md) - 2018-09-30 to 2019-03-31 | money | quarterly_operating_income | 995,000,000 United States dollar | superseded | [clm_A2F6D8E3F671](/claim/clm_A2F6D8E3F671.md) - 2018-09-30 to 2019-03-31 | money | quarterly_research_and_development | 574,000,000 United States dollar | superseded | [clm_41B5CF7870D0](/claim/clm_41B5CF7870D0.md) - 2018-09-30 to 2019-03-31 | money | quarterly_revenue | 7,656,000,000 United States dollar | superseded | [clm_DE1BAF682D4F](/claim/clm_DE1BAF682D4F.md) - 2018-09-30 to 2019-01-31 | money | shares_outstanding | 1,756,333,032 shares | superseded | [clm_66C9CF7C9C4F](/claim/clm_66C9CF7C9C4F.md) - 2018-09-30 to 2018-12-31 | money | total_assets | 71,637,000,000 United States dollar | superseded | [clm_3B31ADE89C36](/claim/clm_3B31ADE89C36.md) - 2018-09-30 to 2018-12-31 | money | total_equity | 30,705,000,000 United States dollar | superseded | [clm_3FB8E64381F1](/claim/clm_3FB8E64381F1.md) - 2018-12-31 to 2019-03-31 | money | cash_and_equivalents | 3,844,000,000 United States dollar | superseded | [clm_CAD5272C9D86](/claim/clm_CAD5272C9D86.md) - 2018-12-31 to 2019-12-31 | money | net_income | 2,368,000,000 United States dollar | superseded | [clm_431C6CD455C6](/claim/clm_431C6CD455C6.md) - 2018-12-31 to 2019-12-31 | money | operating_income | 3,650,000,000 United States dollar | superseded | [clm_B2ED5C0080DE](/claim/clm_B2ED5C0080DE.md) - 2018-12-31 to 2019-12-31 | money | research_and_development | 2,300,000,000 United States dollar | superseded | [clm_0556A1975396](/claim/clm_0556A1975396.md) - 2018-12-31 to 2019-12-31 | money | revenue | 30,578,000,000 United States dollar | superseded | [clm_B704D1D4A319](/claim/clm_B704D1D4A319.md) - 2018-12-31 to 2019-03-31 | money | total_assets | 67,173,000,000 United States dollar | superseded | [clm_1558E1C3AC44](/claim/clm_1558E1C3AC44.md) - 2018-12-31 to 2019-03-31 | money | total_equity | 30,524,000,000 United States dollar | superseded | [clm_CD188CE803B5](/claim/clm_CD188CE803B5.md) ## 2019 - 2019-01-31 to 2019-03-31 | money | shares_outstanding | 1,756,470,269 shares | superseded | [clm_2216B46B8180](/claim/clm_2216B46B8180.md) - 2019-03-31 to 2019-06-30 | money | cash_and_equivalents | 3,022,000,000 United States dollar | superseded | [clm_166B1C725C2A](/claim/clm_166B1C725C2A.md) - 2019-03-31 to 2019-06-30 | money | quarterly_net_income | 672,000,000 United States dollar | superseded | [clm_7FCB849C8A66](/claim/clm_7FCB849C8A66.md) - 2019-03-31 to 2019-06-30 | money | quarterly_operating_income | 739,000,000 United States dollar | superseded | [clm_8F33F13465E8](/claim/clm_8F33F13465E8.md) - 2019-03-31 to 2019-06-30 | money | quarterly_research_and_development | 672,000,000 United States dollar | superseded | [clm_235E5A9BD334](/claim/clm_235E5A9BD334.md) - 2019-03-31 to 2019-06-30 | money | quarterly_revenue | 7,535,000,000 United States dollar | superseded | [clm_C0322CACEF5F](/claim/clm_C0322CACEF5F.md) - 2019-03-31 to 2019-06-30 | money | shares_outstanding | 1,764,181,262 shares | superseded | [clm_24ACD32E0696](/claim/clm_24ACD32E0696.md) - 2019-03-31 to 2019-06-30 | money | total_assets | 67,610,000,000 United States dollar | superseded | [clm_6BF87C6DF992](/claim/clm_6BF87C6DF992.md) - 2019-03-31 to 2019-06-30 | money | total_equity | 30,925,000,000 United States dollar | superseded | [clm_7D62673F73F6](/claim/clm_7D62673F73F6.md) - 2019-06-30 to 2019-09-30 | money | cash_and_equivalents | 3,137,000,000 United States dollar | superseded | [clm_D60E926E5D8D](/claim/clm_D60E926E5D8D.md) - 2019-06-30 to 2019-09-30 | money | quarterly_net_income | 1,006,000,000 United States dollar | superseded | [clm_CEF1F2D39061](/claim/clm_CEF1F2D39061.md) - 2019-06-30 to 2019-09-30 | money | quarterly_operating_income | 1,206,000,000 United States dollar | superseded | [clm_2F19688C782C](/claim/clm_2F19688C782C.md) - 2019-06-30 to 2019-09-30 | money | quarterly_research_and_development | 577,000,000 United States dollar | superseded | [clm_C910D6802F6E](/claim/clm_C910D6802F6E.md) - 2019-06-30 to 2019-09-30 | money | quarterly_revenue | 7,979,000,000 United States dollar | superseded | [clm_BDDE4A079F3F](/claim/clm_BDDE4A079F3F.md) - 2019-06-30 to 2019-09-30 | money | shares_outstanding | 1,767,397,615 shares | superseded | [clm_8048076BF037](/claim/clm_8048076BF037.md) - 2019-06-30 to 2019-09-30 | money | total_assets | 68,427,000,000 United States dollar | superseded | [clm_B5CB1DFE9334](/claim/clm_B5CB1DFE9334.md) - 2019-06-30 to 2019-09-30 | money | total_equity | 31,686,000,000 United States dollar | superseded | [clm_B94747095EFB](/claim/clm_B94747095EFB.md) - 2019-09-30 to 2019-12-31 | money | cash_and_equivalents | 4,091,000,000 United States dollar | superseded | [clm_D5F76318A6D2](/claim/clm_D5F76318A6D2.md) - 2019-09-30 to 2020-03-31 | money | quarterly_net_income | 960,000,000 United States dollar | superseded | [clm_E5DF870B61C4](/claim/clm_E5DF870B61C4.md) - 2019-09-30 to 2020-03-31 | money | quarterly_operating_income | 1,198,000,000 United States dollar | superseded | [clm_79BB0F5ED4DC](/claim/clm_79BB0F5ED4DC.md) - 2019-09-30 to 2020-03-31 | money | quarterly_research_and_development | 596,000,000 United States dollar | superseded | [clm_D72480210DBD](/claim/clm_D72480210DBD.md) - 2019-09-30 to 2020-03-31 | money | quarterly_revenue | 8,076,000,000 United States dollar | superseded | [clm_6EA4DA762D97](/claim/clm_6EA4DA762D97.md) - 2019-09-30 to 2020-01-31 | money | shares_outstanding | 1,768,455,705 shares | superseded | [clm_18993939AE37](/claim/clm_18993939AE37.md) - 2019-09-30 to 2019-12-31 | money | total_assets | 68,539,000,000 United States dollar | superseded | [clm_272419186E81](/claim/clm_272419186E81.md) - 2019-09-30 to 2019-12-31 | money | total_equity | 31,817,000,000 United States dollar | superseded | [clm_6AC71DAEDCE7](/claim/clm_6AC71DAEDCE7.md) - 2019-12-31 to 2020-03-31 | money | cash_and_equivalents | 3,860,000,000 United States dollar | superseded | [clm_6379D6E6764E](/claim/clm_6379D6E6764E.md) - 2019-12-31 to 2020-12-31 | money | net_income | 3,687,000,000 United States dollar | superseded | [clm_82D437604E1A](/claim/clm_82D437604E1A.md) - 2019-12-31 to 2020-12-31 | money | operating_income | 4,532,000,000 United States dollar | superseded | [clm_50D9545CB1D5](/claim/clm_50D9545CB1D5.md) - 2019-12-31 to 2020-12-31 | money | research_and_development | 2,440,000,000 United States dollar | superseded | [clm_E3A1981FFAA1](/claim/clm_E3A1981FFAA1.md) - 2019-12-31 to 2020-12-31 | money | revenue | 31,904,000,000 United States dollar | superseded | [clm_1395DECF0604](/claim/clm_1395DECF0604.md) - 2019-12-31 to 2020-03-31 | money | total_assets | 67,887,000,000 United States dollar | superseded | [clm_13B501924E09](/claim/clm_13B501924E09.md) - 2019-12-31 to 2020-03-31 | money | total_equity | 31,088,000,000 United States dollar | superseded | [clm_1226C199906C](/claim/clm_1226C199906C.md) ## 2020 - 2020-01-31 to 2020-03-31 | money | shares_outstanding | 1,763,433,243 shares | superseded | [clm_4CC142CFD436](/claim/clm_4CC142CFD436.md) - 2020-03-31 to 2020-06-30 | money | cash_and_equivalents | 3,377,000,000 United States dollar | superseded | [clm_9ABE667349AF](/claim/clm_9ABE667349AF.md) - 2020-03-31 to 2020-06-30 | money | quarterly_net_income | 564,000,000 United States dollar | superseded | [clm_3BBCD8D2245C](/claim/clm_3BBCD8D2245C.md) - 2020-03-31 to 2020-06-30 | money | quarterly_operating_income | 758,000,000 United States dollar | superseded | [clm_E25EFE866047](/claim/clm_E25EFE866047.md) - 2020-03-31 to 2020-06-30 | money | quarterly_research_and_development | 578,000,000 United States dollar | superseded | [clm_5BDD75D9E730](/claim/clm_5BDD75D9E730.md) - 2020-03-31 to 2020-06-30 | money | quarterly_revenue | 7,726,000,000 United States dollar | superseded | [clm_0C0541A5EB25](/claim/clm_0C0541A5EB25.md) - 2020-03-31 to 2020-06-30 | money | shares_outstanding | 1,768,845,326 shares | superseded | [clm_321196ABECC8](/claim/clm_321196ABECC8.md) - 2020-03-31 to 2020-06-30 | money | total_assets | 66,777,000,000 United States dollar | superseded | [clm_A0B8EEF54F83](/claim/clm_A0B8EEF54F83.md) - 2020-03-31 to 2020-06-30 | money | total_equity | 30,218,000,000 United States dollar | superseded | [clm_178BA35B231F](/claim/clm_178BA35B231F.md) - 2020-06-30 to 2020-09-30 | money | cash_and_equivalents | 4,763,000,000 United States dollar | superseded | [clm_4B2593012B5B](/claim/clm_4B2593012B5B.md) - 2020-06-30 to 2020-09-30 | money | quarterly_net_income | 537,000,000 United States dollar | superseded | [clm_095EBCF0260A](/claim/clm_095EBCF0260A.md) - 2020-06-30 to 2020-09-30 | money | quarterly_operating_income | 672,000,000 United States dollar | superseded | [clm_5F9689E3114D](/claim/clm_5F9689E3114D.md) - 2020-06-30 to 2020-09-30 | money | quarterly_research_and_development | 564,000,000 United States dollar | superseded | [clm_BB551BCBB517](/claim/clm_BB551BCBB517.md) - 2020-06-30 to 2020-09-30 | money | quarterly_revenue | 7,328,000,000 United States dollar | superseded | [clm_9EA536FA1B5B](/claim/clm_9EA536FA1B5B.md) - 2020-06-30 to 2020-09-30 | money | shares_outstanding | 1,770,529,999 shares | superseded | [clm_A9B16D8709AE](/claim/clm_A9B16D8709AE.md) - 2020-06-30 to 2020-09-30 | money | total_assets | 68,776,000,000 United States dollar | superseded | [clm_36D0A18F3352](/claim/clm_36D0A18F3352.md) - 2020-06-30 to 2020-09-30 | money | total_equity | 30,578,000,000 United States dollar | superseded | [clm_1795E98E8729](/claim/clm_1795E98E8729.md) - 2020-09-30 to 2020-12-31 | money | cash_and_equivalents | 4,480,000,000 United States dollar | superseded | [clm_9F84425DB42F](/claim/clm_9F84425DB42F.md) - 2020-09-30 to 2021-03-31 | money | quarterly_net_income | 1,232,000,000 United States dollar | superseded | [clm_146580C19233](/claim/clm_146580C19233.md) - 2020-09-30 to 2021-03-31 | money | quarterly_operating_income | 1,495,000,000 United States dollar | superseded | [clm_8501CF976D96](/claim/clm_8501CF976D96.md) - 2020-09-30 to 2021-03-31 | money | quarterly_research_and_development | 580,000,000 United States dollar | superseded | [clm_5227340047B9](/claim/clm_5227340047B9.md) - 2020-09-30 to 2021-03-31 | money | quarterly_revenue | 8,853,000,000 United States dollar | superseded | [clm_3B0F0FD9892A](/claim/clm_3B0F0FD9892A.md) - 2020-09-30 to 2021-01-31 | money | shares_outstanding | 1,772,361,581 shares | superseded | [clm_2A5B8E7E3E6F](/claim/clm_2A5B8E7E3E6F.md) - 2020-09-30 to 2020-12-31 | money | total_assets | 69,043,000,000 United States dollar | superseded | [clm_4FE2013C1FF1](/claim/clm_4FE2013C1FF1.md) - 2020-09-30 to 2020-12-31 | money | total_equity | 31,386,000,000 United States dollar | superseded | [clm_2CE5107EE0B2](/claim/clm_2CE5107EE0B2.md) - 2020-12-31 to 2021-03-31 | money | cash_and_equivalents | 6,838,000,000 United States dollar | superseded | [clm_A8B28B659942](/claim/clm_A8B28B659942.md) - 2020-12-31 to 2021-12-31 | money | net_income | 4,495,000,000 United States dollar | superseded | [clm_492C7215F04B](/claim/clm_492C7215F04B.md) - 2020-12-31 to 2021-12-31 | money | operating_income | 5,357,000,000 United States dollar | superseded | [clm_3EFF550A655C](/claim/clm_3EFF550A655C.md) - 2020-12-31 to 2021-12-31 | money | research_and_development | 2,420,000,000 United States dollar | superseded | [clm_CCB485006F63](/claim/clm_CCB485006F63.md) - 2020-12-31 to 2021-12-31 | money | revenue | 34,608,000,000 United States dollar | superseded | [clm_C6D9CE4452DC](/claim/clm_C6D9CE4452DC.md) - 2020-12-31 to 2021-03-31 | money | total_assets | 72,548,000,000 United States dollar | superseded | [clm_B337C7B6BC7D](/claim/clm_B337C7B6BC7D.md) - 2020-12-31 to 2021-03-31 | money | total_equity | 32,784,000,000 United States dollar | superseded | [clm_E91F357595A5](/claim/clm_E91F357595A5.md) ## 2021 - 2021-01-31 to 2021-03-31 | money | shares_outstanding | 1,771,529,358 shares | superseded | [clm_826A1DC08AE8](/claim/clm_826A1DC08AE8.md) - 2021-03-31 to 2021-06-30 | money | cash_and_equivalents | 8,054,000,000 United States dollar | superseded | [clm_6CBAE76E6610](/claim/clm_6CBAE76E6610.md) - 2021-03-31 to 2021-06-30 | money | quarterly_net_income | 1,793,000,000 United States dollar | superseded | [clm_9F497245599A](/claim/clm_9F497245599A.md) - 2021-03-31 to 2021-06-30 | money | quarterly_operating_income | 2,109,000,000 United States dollar | superseded | [clm_57D24A3D8A74](/claim/clm_57D24A3D8A74.md) - 2021-03-31 to 2021-06-30 | money | quarterly_research_and_development | 654,000,000 United States dollar | superseded | [clm_99642DE8DD5D](/claim/clm_99642DE8DD5D.md) - 2021-03-31 to 2021-06-30 | money | quarterly_revenue | 10,456,000,000 United States dollar | superseded | [clm_336AC8B041A1](/claim/clm_336AC8B041A1.md) - 2021-03-31 to 2021-06-30 | money | shares_outstanding | 1,776,820,148 shares | superseded | [clm_1F524FFD747D](/claim/clm_1F524FFD747D.md) - 2021-03-31 to 2021-06-30 | money | total_assets | 72,785,000,000 United States dollar | superseded | [clm_3ACBA8D93D83](/claim/clm_3ACBA8D93D83.md) - 2021-03-31 to 2021-06-30 | money | total_equity | 33,562,000,000 United States dollar | superseded | [clm_9B3045B3D04C](/claim/clm_9B3045B3D04C.md) - 2021-06-30 to 2021-09-30 | money | cash_and_equivalents | 8,658,000,000 United States dollar | superseded | [clm_4D07CC32DA31](/claim/clm_4D07CC32DA31.md) - 2021-06-30 to 2021-09-30 | money | quarterly_net_income | 1,189,000,000 United States dollar | superseded | [clm_4D5842D1AFBC](/claim/clm_4D5842D1AFBC.md) - 2021-06-30 to 2021-09-30 | money | quarterly_operating_income | 1,392,000,000 United States dollar | superseded | [clm_23A44C31565F](/claim/clm_23A44C31565F.md) - 2021-06-30 to 2021-09-30 | money | quarterly_research_and_development | 654,000,000 United States dollar | superseded | [clm_258F725B9941](/claim/clm_258F725B9941.md) - 2021-06-30 to 2021-09-30 | money | quarterly_revenue | 10,223,000,000 United States dollar | superseded | [clm_6EAE7D00A853](/claim/clm_6EAE7D00A853.md) - 2021-06-30 to 2021-09-30 | money | shares_outstanding | 1,772,817,349 shares | superseded | [clm_08F7D872BEBD](/claim/clm_08F7D872BEBD.md) - 2021-06-30 to 2021-09-30 | money | total_assets | 73,269,000,000 United States dollar | superseded | [clm_915AC243756D](/claim/clm_915AC243756D.md) - 2021-06-30 to 2021-09-30 | money | total_equity | 33,800,000,000 United States dollar | superseded | [clm_0E0ED6C2D2F1](/claim/clm_0E0ED6C2D2F1.md) - 2021-09-30 to 2021-12-31 | money | cash_and_equivalents | 9,302,000,000 United States dollar | superseded | [clm_B27DA681BF8C](/claim/clm_B27DA681BF8C.md) - 2021-09-30 to 2022-03-31 | money | quarterly_net_income | 2,100,000,000 United States dollar | superseded | [clm_F9C12EA9C926](/claim/clm_F9C12EA9C926.md) - 2021-09-30 to 2022-03-31 | money | quarterly_operating_income | 2,546,000,000 United States dollar | superseded | [clm_48E46D6ED9A6](/claim/clm_48E46D6ED9A6.md) - 2021-09-30 to 2022-03-31 | money | quarterly_research_and_development | 672,000,000 United States dollar | superseded | [clm_F2D32AEB2B4A](/claim/clm_F2D32AEB2B4A.md) - 2021-09-30 to 2022-03-31 | money | quarterly_revenue | 10,928,000,000 United States dollar | superseded | [clm_D28ACE81B29C](/claim/clm_D28ACE81B29C.md) - 2021-09-30 to 2022-01-31 | money | shares_outstanding | 1,768,286,969 shares | superseded | [clm_FC36D396E40F](/claim/clm_FC36D396E40F.md) - 2021-09-30 to 2021-12-31 | money | total_assets | 73,795,000,000 United States dollar | superseded | [clm_8BE27EF7D3B2](/claim/clm_8BE27EF7D3B2.md) - 2021-09-30 to 2021-12-31 | money | total_equity | 34,422,000,000 United States dollar | superseded | [clm_F790E66651DD](/claim/clm_F790E66651DD.md) - 2021-12-31 to 2022-03-31 | money | cash_and_equivalents | 9,799,000,000 United States dollar | superseded | [clm_26D15FF3B04A](/claim/clm_26D15FF3B04A.md) - 2021-12-31 to 2022-12-31 | money | net_income | 7,071,000,000 United States dollar | superseded | [clm_D4753923237F](/claim/clm_D4753923237F.md) - 2021-12-31 to 2022-12-31 | money | operating_income | 8,425,000,000 United States dollar | superseded | [clm_92EA1FC35D1F](/claim/clm_92EA1FC35D1F.md) - 2021-12-31 to 2022-12-31 | money | research_and_development | 2,742,000,000 United States dollar | superseded | [clm_F186D437CBF8](/claim/clm_F186D437CBF8.md) - 2021-12-31 to 2022-12-31 | money | revenue | 43,075,000,000 United States dollar | superseded | [clm_DA5BB69D989B](/claim/clm_DA5BB69D989B.md) - 2021-12-31 to 2022-03-31 | money | total_assets | 75,196,000,000 United States dollar | superseded | [clm_4C989819EA90](/claim/clm_4C989819EA90.md) - 2021-12-31 to 2022-03-31 | money | total_equity | 35,802,000,000 United States dollar | superseded | [clm_962B09128298](/claim/clm_962B09128298.md) ## 2022 - 2022-01-31 to 2022-03-31 | money | shares_outstanding | 1,763,482,267 shares | superseded | [clm_324EB82497B2](/claim/clm_324EB82497B2.md) - 2022-03-31 to 2022-06-30 | money | cash_and_equivalents | 7,675,000,000 United States dollar | superseded | [clm_2441D3B433A5](/claim/clm_2441D3B433A5.md) - 2022-03-31 to 2022-06-30 | money | quarterly_net_income | 2,447,000,000 United States dollar | superseded | [clm_9A8A8D8C7B07](/claim/clm_9A8A8D8C7B07.md) - 2022-03-31 to 2022-06-30 | money | quarterly_operating_income | 2,912,000,000 United States dollar | superseded | [clm_1C12DA1AFF90](/claim/clm_1C12DA1AFF90.md) - 2022-03-31 to 2022-06-30 | money | quarterly_research_and_development | 697,000,000 United States dollar | superseded | [clm_24C066E1F3E1](/claim/clm_24C066E1F3E1.md) - 2022-03-31 to 2022-06-30 | money | quarterly_revenue | 11,895,000,000 United States dollar | superseded | [clm_8A05921A46AB](/claim/clm_8A05921A46AB.md) - 2022-03-31 to 2022-06-30 | money | shares_outstanding | 1,750,942,289 shares | superseded | [clm_CA76322E4A79](/claim/clm_CA76322E4A79.md) - 2022-03-31 to 2022-06-30 | money | total_assets | 74,007,000,000 United States dollar | superseded | [clm_B767032D0C72](/claim/clm_B767032D0C72.md) - 2022-03-31 to 2022-06-30 | money | total_equity | 35,399,000,000 United States dollar | superseded | [clm_44B2ADC81A66](/claim/clm_44B2ADC81A66.md) - 2022-06-30 to 2022-09-30 | money | cash_and_equivalents | 8,937,000,000 United States dollar | superseded | [clm_B9EFB00ADC3F](/claim/clm_B9EFB00ADC3F.md) - 2022-06-30 to 2022-09-30 | money | quarterly_net_income | 2,018,000,000 United States dollar | superseded | [clm_B88C88ADFFAE](/claim/clm_B88C88ADFFAE.md) - 2022-06-30 to 2022-09-30 | money | quarterly_operating_income | 2,376,000,000 United States dollar | superseded | [clm_6DD49D4EE601](/claim/clm_6DD49D4EE601.md) - 2022-06-30 to 2022-09-30 | money | quarterly_research_and_development | 684,000,000 United States dollar | superseded | [clm_D0D6418B59F7](/claim/clm_D0D6418B59F7.md) - 2022-06-30 to 2022-09-30 | money | quarterly_revenue | 11,257,000,000 United States dollar | superseded | [clm_3FFAC71D1875](/claim/clm_3FFAC71D1875.md) - 2022-06-30 to 2022-09-30 | money | shares_outstanding | 1,751,219,743 shares | superseded | [clm_DFFA512578F3](/claim/clm_DFFA512578F3.md) - 2022-06-30 to 2022-09-30 | money | total_assets | 74,202,000,000 United States dollar | superseded | [clm_49EE0D525A68](/claim/clm_49EE0D525A68.md) - 2022-06-30 to 2022-09-30 | money | total_equity | 36,490,000,000 United States dollar | superseded | [clm_D99C678FB2C8](/claim/clm_D99C678FB2C8.md) - 2022-09-30 to 2022-12-31 | money | cash_and_equivalents | 9,594,000,000 United States dollar | superseded | [clm_521772051B63](/claim/clm_521772051B63.md) - 2022-09-30 to 2023-03-31 | money | quarterly_net_income | 1,435,000,000 United States dollar | superseded | [clm_55CCFB617DE7](/claim/clm_55CCFB617DE7.md) - 2022-09-30 to 2023-03-31 | money | quarterly_operating_income | 1,770,000,000 United States dollar | superseded | [clm_886971CE1D04](/claim/clm_886971CE1D04.md) - 2022-09-30 to 2023-03-31 | money | quarterly_research_and_development | 782,000,000 United States dollar | superseded | [clm_6768B441C8E0](/claim/clm_6768B441C8E0.md) - 2022-09-30 to 2023-03-31 | money | quarterly_revenue | 10,410,000,000 United States dollar | superseded | [clm_1EE7A5C106ED](/claim/clm_1EE7A5C106ED.md) - 2022-09-30 to 2023-01-31 | money | shares_outstanding | 1,743,573,777 shares | superseded | [clm_A47E0BC1EDCE](/claim/clm_A47E0BC1EDCE.md) - 2022-09-30 to 2022-12-31 | money | total_assets | 72,801,000,000 United States dollar | superseded | [clm_491BC57BD504](/claim/clm_491BC57BD504.md) - 2022-09-30 to 2022-12-31 | money | total_equity | 35,675,000,000 United States dollar | superseded | [clm_2C9B44DDBA52](/claim/clm_2C9B44DDBA52.md) - 2022-12-31 to 2023-03-31 | money | cash_and_equivalents | 9,882,000,000 United States dollar | superseded | [clm_B5EA4556B88D](/claim/clm_B5EA4556B88D.md) - 2022-12-31 to 2023-12-31 | money | net_income | 6,933,000,000 United States dollar | superseded | [clm_11981DF05BC7](/claim/clm_11981DF05BC7.md) - 2022-12-31 to 2023-12-31 | money | operating_income | 8,362,000,000 United States dollar | superseded | [clm_504246A9C0D6](/claim/clm_504246A9C0D6.md) - 2022-12-31 to 2023-12-31 | money | research_and_development | 2,888,000,000 United States dollar | superseded | [clm_2B9EF111FA51](/claim/clm_2B9EF111FA51.md) - 2022-12-31 to 2023-12-31 | money | revenue | 43,653,000,000 United States dollar | superseded | [clm_6FD3450A3DD5](/claim/clm_6FD3450A3DD5.md) - 2022-12-31 to 2023-03-31 | money | total_assets | 74,438,000,000 United States dollar | superseded | [clm_A18A3F048BE2](/claim/clm_A18A3F048BE2.md) - 2022-12-31 to 2023-03-31 | money | total_equity | 36,686,000,000 United States dollar | superseded | [clm_B43602CFF805](/claim/clm_B43602CFF805.md) ## 2023 - 2023-01-01 | people | cfo | Philip P. Boudreau | valid | [clm_216BEF8E327D](/claim/clm_216BEF8E327D.md) - 2023-01-31 to 2023-03-31 | money | shares_outstanding | 1,737,946,233 shares | superseded | [clm_415D9C1703CA](/claim/clm_415D9C1703CA.md) - 2023-03-31 to 2023-06-30 | money | cash_and_equivalents | 9,161,000,000 United States dollar | superseded | [clm_14B748327E60](/claim/clm_14B748327E60.md) - 2023-03-31 to 2023-06-30 | money | quarterly_net_income | 1,318,000,000 United States dollar | superseded | [clm_021A4A96F575](/claim/clm_021A4A96F575.md) - 2023-03-31 to 2023-06-30 | money | quarterly_operating_income | 1,509,000,000 United States dollar | superseded | [clm_4B304DFC779C](/claim/clm_4B304DFC779C.md) - 2023-03-31 to 2023-06-30 | money | quarterly_research_and_development | 654,000,000 United States dollar | superseded | [clm_602C8D08E319](/claim/clm_602C8D08E319.md) - 2023-03-31 to 2023-06-30 | money | quarterly_revenue | 9,747,000,000 United States dollar | superseded | [clm_BDD05EB44D8B](/claim/clm_BDD05EB44D8B.md) - 2023-03-31 to 2023-06-30 | money | shares_outstanding | 1,738,946,799 shares | superseded | [clm_570FAE00E73C](/claim/clm_570FAE00E73C.md) - 2023-03-31 to 2023-06-30 | money | total_assets | 73,794,000,000 United States dollar | superseded | [clm_29B334F286FF](/claim/clm_29B334F286FF.md) - 2023-03-31 to 2023-06-30 | money | total_equity | 37,010,000,000 United States dollar | superseded | [clm_BCA71643FBC3](/claim/clm_BCA71643FBC3.md) - 2023-06-30 to 2023-09-30 | money | cash_and_equivalents | 7,835,000,000 United States dollar | superseded | [clm_34B14167D6F5](/claim/clm_34B14167D6F5.md) - 2023-06-30 to 2023-09-30 | money | quarterly_net_income | 1,375,000,000 United States dollar | superseded | [clm_53901BDE4225](/claim/clm_53901BDE4225.md) - 2023-06-30 to 2023-09-30 | money | quarterly_operating_income | 1,542,000,000 United States dollar | superseded | [clm_2E82AF12DD3E](/claim/clm_2E82AF12DD3E.md) - 2023-06-30 to 2023-09-30 | money | quarterly_research_and_development | 715,000,000 United States dollar | superseded | [clm_9ED86C910D2E](/claim/clm_9ED86C910D2E.md) - 2023-06-30 to 2023-09-30 | money | quarterly_revenue | 9,978,000,000 United States dollar | superseded | [clm_6B2DDDB45AF4](/claim/clm_6B2DDDB45AF4.md) - 2023-06-30 to 2023-09-30 | money | shares_outstanding | 1,735,357,980 shares | superseded | [clm_027756C1CA20](/claim/clm_027756C1CA20.md) - 2023-06-30 to 2023-09-30 | money | total_assets | 73,354,000,000 United States dollar | superseded | [clm_58DF422102D3](/claim/clm_58DF422102D3.md) - 2023-06-30 to 2023-09-30 | money | total_equity | 37,174,000,000 United States dollar | superseded | [clm_2FAA1610921D](/claim/clm_2FAA1610921D.md) - 2023-09-30 to 2023-12-31 | money | cash_and_equivalents | 6,709,000,000 United States dollar | superseded | [clm_01C8A8BA9FB2](/claim/clm_01C8A8BA9FB2.md) - 2023-09-30 to 2024-03-31 | money | quarterly_net_income | 1,436,000,000 United States dollar | superseded | [clm_47F26EE33149](/claim/clm_47F26EE33149.md) - 2023-09-30 to 2024-03-31 | money | quarterly_operating_income | 1,647,000,000 United States dollar | superseded | [clm_B41FB990A838](/claim/clm_B41FB990A838.md) - 2023-09-30 to 2024-03-31 | money | quarterly_research_and_development | 672,000,000 United States dollar | superseded | [clm_F557BBEDA577](/claim/clm_F557BBEDA577.md) - 2023-09-30 to 2024-03-31 | money | quarterly_revenue | 10,143,000,000 United States dollar | superseded | [clm_3885AF18E04D](/claim/clm_3885AF18E04D.md) - 2023-09-30 to 2024-01-31 | money | shares_outstanding | 1,736,058,536 shares | superseded | [clm_DDC41F7C4050](/claim/clm_DDC41F7C4050.md) - 2023-09-30 to 2023-12-31 | money | total_assets | 72,090,000,000 United States dollar | superseded | [clm_7F56B9F9D8D3](/claim/clm_7F56B9F9D8D3.md) - 2023-09-30 to 2023-12-31 | money | total_equity | 37,481,000,000 United States dollar | superseded | [clm_44CDC24CAD4E](/claim/clm_44CDC24CAD4E.md) - 2023-12-31 to 2024-03-31 | money | cash_and_equivalents | 6,896,000,000 United States dollar | superseded | [clm_658B87946AB9](/claim/clm_658B87946AB9.md) - 2023-12-31 to 2024-12-31 | money | net_income | 5,723,000,000 United States dollar | superseded | [clm_1E79DAD01E1C](/claim/clm_1E79DAD01E1C.md) - 2023-12-31 to 2024-12-31 | money | operating_income | 6,478,000,000 United States dollar | superseded | [clm_492DDC48ED34](/claim/clm_492DDC48ED34.md) - 2023-12-31 to 2024-12-31 | money | research_and_development | 2,741,000,000 United States dollar | superseded | [clm_616A4BA20B30](/claim/clm_616A4BA20B30.md) - 2023-12-31 to 2024-12-31 | money | revenue | 40,109,000,000 United States dollar | superseded | [clm_8BADD4D79F8F](/claim/clm_8BADD4D79F8F.md) - 2023-12-31 to 2024-03-31 | money | total_assets | 73,214,000,000 United States dollar | superseded | [clm_603966F4450A](/claim/clm_603966F4450A.md) - 2023-12-31 to 2024-03-31 | money | total_equity | 38,603,000,000 United States dollar | superseded | [clm_5BE6B18DE8F9](/claim/clm_5BE6B18DE8F9.md) ## 2024 - 2024-01-31 to 2024-03-31 | money | shares_outstanding | 1,735,184,289 shares | superseded | [clm_BBA1010F4237](/claim/clm_BBA1010F4237.md) - 2024-03-31 to 2024-06-30 | money | cash_and_equivalents | 6,284,000,000 United States dollar | superseded | [clm_BE85A98DAC5B](/claim/clm_BE85A98DAC5B.md) - 2024-03-31 to 2024-06-30 | money | quarterly_net_income | 1,225,000,000 United States dollar | superseded | [clm_B072725BD09E](/claim/clm_B072725BD09E.md) - 2024-03-31 to 2024-06-30 | money | quarterly_operating_income | 1,386,000,000 United States dollar | superseded | [clm_FDE13F28F4C1](/claim/clm_FDE13F28F4C1.md) - 2024-03-31 to 2024-06-30 | money | quarterly_research_and_development | 684,000,000 United States dollar | superseded | [clm_67490CE86700](/claim/clm_67490CE86700.md) - 2024-03-31 to 2024-06-30 | money | quarterly_revenue | 9,964,000,000 United States dollar | superseded | [clm_60D18C4ED290](/claim/clm_60D18C4ED290.md) - 2024-03-31 to 2024-06-30 | money | shares_outstanding | 1,739,633,759 shares | superseded | [clm_97F2C8360ADC](/claim/clm_97F2C8360ADC.md) - 2024-03-31 to 2024-06-30 | money | total_assets | 72,467,000,000 United States dollar | superseded | [clm_A3E39CBB1AE7](/claim/clm_A3E39CBB1AE7.md) - 2024-03-31 to 2024-06-30 | money | total_equity | 38,810,000,000 United States dollar | superseded | [clm_C93071E72423](/claim/clm_C93071E72423.md) - 2024-06-30 to 2024-09-30 | money | cash_and_equivalents | 6,987,000,000 United States dollar | superseded | [clm_16E584C7B895](/claim/clm_16E584C7B895.md) - 2024-06-30 to 2024-09-30 | money | quarterly_net_income | 1,302,000,000 United States dollar | superseded | [clm_B3E333AEC169](/claim/clm_B3E333AEC169.md) - 2024-06-30 to 2024-09-30 | money | quarterly_operating_income | 1,669,000,000 United States dollar | superseded | [clm_D714148AE67A](/claim/clm_D714148AE67A.md) - 2024-06-30 to 2024-09-30 | money | quarterly_research_and_development | 698,000,000 United States dollar | superseded | [clm_B51405589AC1](/claim/clm_B51405589AC1.md) - 2024-06-30 to 2024-09-30 | money | quarterly_revenue | 10,377,000,000 United States dollar | superseded | [clm_BC21405CF5E5](/claim/clm_BC21405CF5E5.md) - 2024-06-30 to 2024-09-30 | money | shares_outstanding | 1,739,897,004 shares | superseded | [clm_17BF8DBB11AD](/claim/clm_17BF8DBB11AD.md) - 2024-06-30 to 2024-09-30 | money | total_assets | 73,017,000,000 United States dollar | superseded | [clm_73D720E01EFC](/claim/clm_73D720E01EFC.md) - 2024-06-30 to 2024-09-30 | money | total_equity | 39,318,000,000 United States dollar | superseded | [clm_963EBDDEF424](/claim/clm_963EBDDEF424.md) - 2024-09-30 to 2024-12-31 | money | cash_and_equivalents | 7,558,000,000 United States dollar | superseded | [clm_1FFA2B3FBAF9](/claim/clm_1FFA2B3FBAF9.md) - 2024-09-30 to 2025-03-31 | money | quarterly_net_income | 1,646,000,000 United States dollar | superseded | [clm_489645837B5D](/claim/clm_489645837B5D.md) - 2024-09-30 to 2025-03-31 | money | quarterly_operating_income | 1,859,000,000 United States dollar | superseded | [clm_23C6088E7F70](/claim/clm_23C6088E7F70.md) - 2024-09-30 to 2025-03-31 | money | quarterly_research_and_development | 713,000,000 United States dollar | superseded | [clm_4031E5A84FE8](/claim/clm_4031E5A84FE8.md) - 2024-09-30 to 2025-03-31 | money | quarterly_revenue | 10,635,000,000 United States dollar | superseded | [clm_12D7EF8B99CE](/claim/clm_12D7EF8B99CE.md) - 2024-09-30 to 2025-01-31 | money | shares_outstanding | 1,734,455,213 shares | superseded | [clm_B9E574E3CE32](/claim/clm_B9E574E3CE32.md) - 2024-09-30 to 2024-12-31 | money | total_assets | 74,356,000,000 United States dollar | superseded | [clm_BCEDE84B5D8A](/claim/clm_BCEDE84B5D8A.md) - 2024-09-30 to 2024-12-31 | money | total_equity | 39,796,000,000 United States dollar | superseded | [clm_CE6B68D9DE0E](/claim/clm_CE6B68D9DE0E.md) - 2024-12-31 to 2025-03-31 | money | cash_and_equivalents | 7,616,000,000 United States dollar | superseded | [clm_BE323442D575](/claim/clm_BE323442D575.md) - 2024-12-31 to 2025-12-31 | money | net_income | 13,402,000,000 United States dollar | superseded | [clm_CF3E98D0B268](/claim/clm_CF3E98D0B268.md) - 2024-12-31 to 2025-12-31 | money | operating_income | 6,825,000,000 United States dollar | superseded | [clm_6578DDE458E0](/claim/clm_6578DDE458E0.md) - 2024-12-31 to 2025-12-31 | money | research_and_development | 2,844,000,000 United States dollar | superseded | [clm_AD76C5C835C9](/claim/clm_AD76C5C835C9.md) - 2024-12-31 to 2025-12-31 | money | revenue | 41,950,000,000 United States dollar | superseded | [clm_AC0EC8434FB1](/claim/clm_AC0EC8434FB1.md) - 2024-12-31 to 2025-03-31 | money | total_assets | 81,414,000,000 United States dollar | superseded | [clm_114AF086ADE9](/claim/clm_114AF086ADE9.md) - 2024-12-31 to 2025-03-31 | money | total_equity | 47,664,000,000 United States dollar | superseded | [clm_117E87574745](/claim/clm_117E87574745.md) ## 2025 - 2025-01-31 to 2025-03-31 | money | shares_outstanding | 1,734,323,411 shares | superseded | [clm_C9A2257584AB](/claim/clm_C9A2257584AB.md) - 2025-03-31 to 2025-06-30 | money | cash_and_equivalents | 6,532,000,000 United States dollar | superseded | [clm_7C1DF4950D60](/claim/clm_7C1DF4950D60.md) - 2025-03-31 to 2025-06-30 | money | quarterly_net_income | 1,325,000,000 United States dollar | superseded | [clm_1188A2534E22](/claim/clm_1188A2534E22.md) - 2025-03-31 to 2025-06-30 | money | quarterly_operating_income | 1,693,000,000 United States dollar | superseded | [clm_75BE91C87765](/claim/clm_75BE91C87765.md) - 2025-03-31 to 2025-06-30 | money | quarterly_research_and_development | 716,000,000 United States dollar | superseded | [clm_5AF0089A1631](/claim/clm_5AF0089A1631.md) - 2025-03-31 to 2025-06-30 | money | quarterly_revenue | 10,358,000,000 United States dollar | superseded | [clm_B19E42064034](/claim/clm_B19E42064034.md) - 2025-03-31 to 2025-06-30 | money | shares_outstanding | 1,739,836,465 shares | superseded | [clm_D943BAA75A0F](/claim/clm_D943BAA75A0F.md) - 2025-03-31 to 2025-06-30 | money | total_assets | 81,448,000,000 United States dollar | superseded | [clm_27D6994F8B52](/claim/clm_27D6994F8B52.md) - 2025-03-31 to 2025-06-30 | money | total_equity | 48,811,000,000 United States dollar | superseded | [clm_263DBDF600A7](/claim/clm_263DBDF600A7.md) - 2025-06-30 to 2025-09-30 | money | cash_and_equivalents | 6,951,000,000 United States dollar | superseded | [clm_F462DB1216CF](/claim/clm_F462DB1216CF.md) - 2025-06-30 to 2025-09-30 | money | quarterly_net_income | 1,779,000,000 United States dollar | superseded | [clm_E37C754C8FCC](/claim/clm_E37C754C8FCC.md) - 2025-06-30 to 2025-09-30 | money | quarterly_operating_income | 2,052,000,000 United States dollar | superseded | [clm_D4D65248DFB6](/claim/clm_D4D65248DFB6.md) - 2025-06-30 to 2025-09-30 | money | quarterly_research_and_development | 725,000,000 United States dollar | superseded | [clm_B9E52815E3A9](/claim/clm_B9E52815E3A9.md) - 2025-06-30 to 2025-09-30 | money | quarterly_revenue | 11,142,000,000 United States dollar | superseded | [clm_E9EFA461ED0C](/claim/clm_E9EFA461ED0C.md) - 2025-06-30 to 2025-09-30 | money | shares_outstanding | 1,740,459,014 shares | superseded | [clm_F9BD3860CF3E](/claim/clm_F9BD3860CF3E.md) - 2025-06-30 to 2025-09-30 | money | total_assets | 83,999,000,000 United States dollar | superseded | [clm_217C000CA5A2](/claim/clm_217C000CA5A2.md) - 2025-06-30 to 2025-09-30 | money | total_equity | 50,565,000,000 United States dollar | superseded | [clm_11FDBB86160D](/claim/clm_11FDBB86160D.md) - 2025-09-30 to 2025-12-31 | money | cash_and_equivalents | 7,511,000,000 United States dollar | superseded | [clm_4D88D9F7190C](/claim/clm_4D88D9F7190C.md) - 2025-09-30 to 2026-03-31 | money | quarterly_net_income | 1,644,000,000 United States dollar | superseded | [clm_2BCC0DA601EA](/claim/clm_2BCC0DA601EA.md) - 2025-09-30 to 2026-03-31 | money | quarterly_operating_income | 2,057,000,000 United States dollar | superseded | [clm_94C2592AE159](/claim/clm_94C2592AE159.md) - 2025-09-30 to 2026-03-31 | money | quarterly_research_and_development | 766,000,000 United States dollar | superseded | [clm_1266BBB313EF](/claim/clm_1266BBB313EF.md) - 2025-09-30 to 2026-03-31 | money | quarterly_revenue | 11,369,000,000 United States dollar | superseded | [clm_4D4D4E6FC869](/claim/clm_4D4D4E6FC869.md) - 2025-09-30 to 2026-01-31 | money | shares_outstanding | 1,738,871,947 shares | superseded | [clm_0F8EC0C78816](/claim/clm_0F8EC0C78816.md) - 2025-09-30 to 2025-12-31 | money | total_assets | 84,181,000,000 United States dollar | superseded | [clm_87D9C9A99CA7](/claim/clm_87D9C9A99CA7.md) - 2025-09-30 to 2025-12-31 | money | total_equity | 50,954,000,000 United States dollar | superseded | [clm_D5EE83B1870A](/claim/clm_D5EE83B1870A.md) - 2025-12-31 to 2026-03-31 | money | cash_and_equivalents | 8,522,000,000 United States dollar | superseded | [clm_C0C2E64C6F88](/claim/clm_C0C2E64C6F88.md) - 2025-12-31 | money | net_income | 6,524,000,000 United States dollar | valid | [clm_76AC317902A6](/claim/clm_76AC317902A6.md) - 2025-12-31 | money | operating_income | 8,053,000,000 United States dollar | valid | [clm_551396362E4C](/claim/clm_551396362E4C.md) - 2025-12-31 | money | research_and_development | 2,942,000,000 United States dollar | valid | [clm_0537D98543E9](/claim/clm_0537D98543E9.md) - 2025-12-31 | money | revenue | 44,328,000,000 United States dollar | valid | [clm_7C1D7352CFA6](/claim/clm_7C1D7352CFA6.md) - 2025-12-31 to 2026-03-31 | money | total_assets | 86,713,000,000 United States dollar | superseded | [clm_61EE170DDFF9](/claim/clm_61EE170DDFF9.md) - 2025-12-31 to 2026-03-31 | money | total_equity | 52,130,000,000 United States dollar | superseded | [clm_233C6F73AC72](/claim/clm_233C6F73AC72.md) ## 2026 - 2026-01-31 to 2026-03-31 | money | shares_outstanding | 1,737,682,887 shares | superseded | [clm_98DC25486509](/claim/clm_98DC25486509.md) - 2026-03-31 to 2026-06-30 | money | cash_and_equivalents | 6,803,000,000 United States dollar | superseded | [clm_F4A9C9EE7593](/claim/clm_F4A9C9EE7593.md) - 2026-03-31 to 2026-06-30 | money | quarterly_net_income | 1,077,000,000 United States dollar | superseded | [clm_0713CDEDD078](/claim/clm_0713CDEDD078.md) - 2026-03-31 to 2026-06-30 | money | quarterly_operating_income | 1,345,000,000 United States dollar | superseded | [clm_1C0A2724D779](/claim/clm_1C0A2724D779.md) - 2026-03-31 to 2026-06-30 | money | quarterly_research_and_development | 767,000,000 United States dollar | superseded | [clm_F408F42211E9](/claim/clm_F408F42211E9.md) - 2026-03-31 to 2026-06-30 | money | quarterly_revenue | 11,164,000,000 United States dollar | superseded | [clm_EF0BC6C103EE](/claim/clm_EF0BC6C103EE.md) - 2026-03-31 to 2026-06-30 | money | shares_outstanding | 1,741,812,429 shares | superseded | [clm_0EA7146A2063](/claim/clm_0EA7146A2063.md) - 2026-03-31 to 2026-06-30 | money | total_assets | 110,429,000,000 United States dollar | superseded | [clm_1E6184001C61](/claim/clm_1E6184001C61.md) - 2026-03-31 to 2026-06-30 | money | total_equity | 52,061,000,000 United States dollar | superseded | [clm_3A1641DA4DD9](/claim/clm_3A1641DA4DD9.md) - 2026-06-30 to 2026-09-30 | money | cash_and_equivalents | 5,104,000,000 United States dollar | superseded | [clm_427132599EAB](/claim/clm_427132599EAB.md) - 2026-06-30 to 2026-09-30 | money | quarterly_net_income | 928,000,000 United States dollar | superseded | [clm_260A61887540](/claim/clm_260A61887540.md) - 2026-06-30 to 2026-09-30 | money | quarterly_operating_income | 1,693,000,000 United States dollar | superseded | [clm_2A39068943F3](/claim/clm_2A39068943F3.md) - 2026-06-30 to 2026-09-30 | money | quarterly_research_and_development | 892,000,000 United States dollar | superseded | [clm_A04DCE763037](/claim/clm_A04DCE763037.md) - 2026-06-30 to 2026-09-30 | money | quarterly_revenue | 12,593,000,000 United States dollar | superseded | [clm_88335AA7BB99](/claim/clm_88335AA7BB99.md) - 2026-06-30 to 2026-09-30 | money | shares_outstanding | 1,730,383,296 shares | superseded | [clm_AC459049B414](/claim/clm_AC459049B414.md) - 2026-06-30 to 2026-09-30 | money | total_assets | 109,215,000,000 United States dollar | superseded | [clm_9F11A9C39281](/claim/clm_9F11A9C39281.md) - 2026-06-30 to 2026-09-30 | money | total_equity | 51,110,000,000 United States dollar | superseded | [clm_6E93433192ED](/claim/clm_6E93433192ED.md) - 2026-09-30 | money | cash_and_equivalents | 4,052,000,000 United States dollar | valid | [clm_D623F1D8651F](/claim/clm_D623F1D8651F.md) - 2026-09-30 | money | quarterly_net_income | 920,000,000 United States dollar | valid | [clm_0E055280C61A](/claim/clm_0E055280C61A.md) - 2026-09-30 | money | quarterly_operating_income | 1,358,000,000 United States dollar | valid | [clm_2416CD508AED](/claim/clm_2416CD508AED.md) - 2026-09-30 | money | quarterly_research_and_development | 920,000,000 United States dollar | valid | [clm_1E22065402A1](/claim/clm_1E22065402A1.md) - 2026-09-30 | money | quarterly_revenue | 13,013,000,000 United States dollar | valid | [clm_080974839279](/claim/clm_080974839279.md) - 2026-09-30 | money | shares_outstanding | 1,731,941,601 shares | valid | [clm_7B940234185D](/claim/clm_7B940234185D.md) - 2026-09-30 | money | total_assets | 108,247,000,000 United States dollar | valid | [clm_408FF4DCACA7](/claim/clm_408FF4DCACA7.md) - 2026-09-30 | money | total_equity | 51,027,000,000 United States dollar | valid | [clm_1774BA675DC1](/claim/clm_1774BA675DC1.md) ## undated - undated | other | headquarters | North Chicago | unverified | [clm_F43E6397059E](/claim/clm_F43E6397059E.md) - undated | other | website | https://abbott.com | unverified | [clm_E677AE124C79](/claim/clm_E677AE124C79.md) - undated | other | cik | 0000001800 | valid | [clm_DC766CB8ACA6](/claim/clm_DC766CB8ACA6.md) - undated | other | fiscal_year_end | 12-31 | valid | [clm_7EA8A2BEA2BF](/claim/clm_7EA8A2BEA2BF.md) - undated | other | headquarters | Abbott Park | valid | [clm_47ECD384B983](/claim/clm_47ECD384B983.md) - undated | other | listed_on | NYSE | valid | [clm_349DE9490A94](/claim/clm_349DE9490A94.md) - undated | other | registrant_name | ABBOTT LABORATORIES | valid | [clm_78E1BC94DC92](/claim/clm_78E1BC94DC92.md) - undated | other | sic_industry | Pharmaceutical Preparations (2834) | valid | [clm_AB7AA73DD6DF](/claim/clm_AB7AA73DD6DF.md) - undated | other | state_of_incorporation | IL | valid | [clm_5EB4D6DCC26A](/claim/clm_5EB4D6DCC26A.md) - undated | other | ticker | ABT | valid | [clm_E39037FF4684](/claim/clm_E39037FF4684.md) --- AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.